Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,4.520633328752815e-40,38.69605263157895,3505.6592767840666,"['RPL4', 'RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPS6KA2', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'MRPL19', 'RPL36A', 'RPS4Y1', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.6581323973066553e-37,0,0,81
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.3647127586707002e-17,6.672216010733453,259.1021817433781,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'NDUFS2', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1B', 'UCP3', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",4.012255510491859e-15,0,0,61
3,Oxidative phosphorylation WP623,6.4650825181110246e-12,7.473090564170241,192.5412290556545,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'ATP6AP2', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO', 'NDUFS2']",1.267156173549761e-09,0,0,37
4,Nonalcoholic fatty liver disease WP4396,3.925660451856469e-09,2.880461474097788,55.75343811641763,"['NDUFA13', 'COX7B', 'GSK3A', 'NDUFA11', 'NDUFA12', 'COX4I1', 'PIK3CD', 'COX6A1', 'COX7C', 'LEPR', 'MLX', 'UQCRFS1', 'RAC1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'NDUFS2', 'PPARA', 'ATF4', 'CEBPA', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'PIK3R3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'ADIPOR1', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'BCL2L11', 'CYC1', 'NDUFA8', 'XBP1', 'JUN', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'NFKB1', 'MLXIPL', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",5.770720864229009e-07,0,0,65
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.1472792397889011e-07,4.60321553162445,73.56261744856083,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'TMEM186', 'TMEM70', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'NDUFS2', 'NDUFAF3', 'TMEM126B']",1.3492003859917476e-05,0,0,31
6,Glycolysis and Gluconeogenesis WP534,4.161120249520693e-06,5.6299913817868426,69.754051893056,"['TPI1', 'GOT1', 'MDH2', 'PGAM1', 'GOT2', 'SLC2A1', 'SLC2A3', 'ENO1', 'ENO2', 'GCK', 'LDHB', 'LDHA', 'PKM', 'MPC2', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'PFKM', 'GAPDH']",0.0004077897844530279,0,0,20
7,Mitochondrial CIV Assembly WP4922,1.7713911787167674e-05,4.690701905582687,51.321721235960034,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'TMEM177', 'SCO2', 'COX14']",0.0014879685901220845,0,0,20
8,"GPCRs, Class A Rhodopsin-like WP455",8.143774383174666e-05,2.529702457573202,23.81884786192697,"['GPR27', 'CHRM2', 'OXTR', 'CHRM1', 'GPR68', 'GPR87', 'GPR22', 'CHRM5', 'GPR85', 'OPRL1', 'GPR83', 'ADRB1', 'ADRA1D', 'MCHR1', 'LTB4R', 'HRH1', 'GPR171', 'PTGDR', 'P2RY12', 'GPR12', 'HTR1E', 'P2RY14', 'SSTR1', 'GPR6', 'ADRA2C', 'HTR5A', 'SSTR3', 'HCRTR2', 'MAS1', 'ADORA2A', 'LPAR6', 'FSHR', 'ACKR4', 'OR6A2', 'OR3A2']",0.005985674171633379,0,0,35
9,Computational Model of Aerobic Glycolysis WP4629,0.00019206767747051003,12.637886597938145,108.15077151969413,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'SLC2A1', 'ENO1', 'ALDOA', 'GAPDH', 'PFKM']",0.012548421594739987,0,0,9
10,Proximal tubule transport WP4917,0.00024097389731187109,3.5628183036569023,29.681204893224965,"['ATP6V1G1', 'ATP6V0B', 'SLC22A6', 'SLC47A1', 'ABCB1', 'SLC2A1', 'SLC3A1', 'SLC16A10', 'ATP1A1', 'ATP1B1', 'SLC5A8', 'SLC7A9', 'CA4', 'ATP6V1E1', 'SLC22A8', 'ATP6V0C', 'ATP6V1D', 'ATP6V1C1', 'ATP6V1F']",0.014169265161938019,0,0,19
11,Exercise-induced Circadian Regulation WP410,0.0009547373879321175,2.690578252121424,18.710480918511234,"['IDI1', 'DAZAP2', 'HSPA8', 'GSTM3', 'CEBPB', 'BTG1', 'RBPMS', 'GSTP1', 'NCOA4', 'GFRA1', 'NR1D2', 'AZIN1', 'HERPUD1', 'PER2', 'DNAJA1', 'PPP2CB', 'SUMO1', 'STBD1', 'UCP3', 'SUMO3', 'ERC2', 'EIF4G2']",0.051035053100371375,0,0,22
12,Myometrial relaxation and contraction pathways WP289,0.0013721171498069994,1.8260858930718902,12.036463226072406,"['RYR1', 'YWHAE', 'RYR2', 'OXTR', 'RGS19', 'RGS14', 'YWHAB', 'ITPR2', 'ATP2A2', 'RXFP1', 'ETS2', 'ACTB', 'ACTG1', 'RGS4', 'GNG3', 'GRK5', 'YWHAQ', 'RGS20', 'IGFBP6', 'YWHAG', 'CORIN', 'YWHAH', 'PRKCG', 'JUN', 'PRKCH', 'IGFBP5', 'IGFBP4', 'GSTO1', 'IGFBP3', 'PDE4D', 'IGFBP2', 'PRKCD', 'FOS', 'NFKB1', 'ACTA2', 'CREB3', 'ADCY9', 'ACTC1', 'PRKAR1A', 'PRKCQ', 'CALM3', 'PRKD1', 'ATF5', 'CALM1', 'CALM2', 'ATF4']",0.06723374034054297,0,0,46
13,HIF1A and PPARG regulation of glycolysis WP2456,0.0017906285188576771,16.837768240343348,106.5020596038312,"['LDHA', 'TPI1', 'SLC2A1', 'GPAT3', 'PPARG', 'GAPDH']",0.0809915053144857,0,0,6
14,Selenium Micronutrient Network WP15,0.0027269830025382466,2.3793972626970614,14.049292493217736,"['GPX4', 'GPX3', 'DIO1', 'APOA1', 'TXN', 'KMO', 'SELENOK', 'SOD2', 'NFKB1', 'SELENOH', 'SOD1', 'PRDX3', 'SELENOM', 'PRDX5', 'SELENOS', 'RFK', 'PRDX1', 'SELENOW', 'PNPO', 'SELENOT', 'SEPHS2', 'MSRB1']",0.11453328610660636,0,0,22
15,Imatinib and Chronic Myeloid Leukemia WP3640,0.0031422767505341763,5.05360824742268,29.122972329081602,"['PDGFRA', 'SPRED2', 'ABCB1', 'CDKN1B', 'GADD45A', 'ABL1', 'GAB2', 'PIM2', 'SKP2']",0.12317724862093972,0,0,9
16,Transcriptional cascade regulating adipogenesis WP4211,0.004775050810158788,6.548559435222286,34.997797967413305,"['CEBPA', 'CEBPB', 'EGR2', 'KLF5', 'DDIT3', 'PPARG', 'KLF15']",0.17548311727333543,0,0,7
17,Cellular Proteostasis WP4918,0.005888045382044419,14.027459954233409,72.02863888999214,"['VBP1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",0.20365709909659518,0,0,5
18,Cori Cycle WP1946,0.007854180841887931,4.490810191812196,21.765651510596857,"['LDHA', 'TPI1', 'PGAM1', 'SLC2A1', 'PGK1', 'GPT', 'ALDOA', 'GAPDH']",0.2565699075016724,0,0,8
19,Metapathway biotransformation Phase I and II WP702,0.009054413759362789,1.7391824212706821,8.181988800054114,"['GAL3ST1', 'GSTP1', 'MGST1', 'GLYAT', 'HS6ST1', 'CYP2C18', 'NAT14', 'CYP3A5', 'HS6ST2', 'NAA80', 'CYP3A7', 'CYP26B1', 'CYP1B1', 'SULT4A1', 'SULT1A2', 'CHST8', 'GSTM3', 'CHST9', 'GLYATL2', 'GPX4', 'GPX3', 'GSTO1', 'CYP3A43', 'KCNAB1', 'HS3ST5', 'FMO5', 'HS3ST4', 'HS3ST2', 'CYP27A1', 'CYP39A1', 'CYP2C8', 'CHST1', 'NAT8L', 'CHST2']",0.2802102784476484,0,0,34
20,NAD Biosynthesis II (from tryptophan) WP2485,0.016131621609250326,7.013014874141876,28.942529052447636,"['TDO2', 'NMNAT1', 'HAAO', 'KMO', 'NADSYN1']",0.47426967531195957,0,0,5
21,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.018878295783541124,11.218758936231055,44.53558289037295,"['COX8A', 'CYP2C8', 'GSTP1', 'COX5A']",0.5045653600328264,0,0,4
22,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.018878295783541124,11.218758936231055,44.53558289037295,"['CYP2C8', 'PPARG', 'PPARA', 'CYP2C18']",0.5045653600328264,0,0,4
23,Pathways in clear cell renal cell carcinoma WP4018,0.019871381018353434,1.7248586905322656,6.758815178128821,"['BHLHE41', 'SLC2A1', 'PLOD2', 'ENO1', 'ENO2', 'ACACB', 'ACACA', 'RPTOR', 'LDHB', 'LDHA', 'DEPTOR', 'PGK1', 'KCNJ2', 'PDGFRA', 'TPI1', 'TGFB1', 'ACLY', 'TOX2', 'PKM', 'ZEB1', 'ALDOC', 'ALDOB', 'CAMK1', 'ALDOA', 'GAPDH', 'PFKM', 'BAP1']",0.5080161755996443,0,0,27
24,Sleep regulation WP3591,0.02160125550863178,2.573233046800382,9.868358617190992,"['CHRNB2', 'OXTR', 'NLGN1', 'AHCY', 'STAR', 'ADORA2A', 'IL18', 'GHRL', 'FOS', 'HCRTR2', 'PTGDR']",0.5292307599614786,0,0,11
25,Mitochondrial complex III assembly WP4921,0.02340086979789283,3.2070671956157213,12.042479869607911,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.5376507432261166,0,0,8
26,Translation Factors WP107,0.02377367231952216,1.8728334769702193,7.002854954834926,"['EIF4A2', 'EIF2B2', 'EIF1AY', 'EIF1AX', 'EEF2', 'GSPT2', 'EIF1', 'EEF1B2', 'EEF1G', 'EEF1A1', 'EIF5', 'EIF6', 'EIF3I', 'EEF1A2', 'EIF4H', 'EIF3G', 'EIF3CL', 'EIF3D', 'EIF4B', 'EIF4G1']",0.5376507432261166,0,0,20
27,VEGFA-VEGFR2 Signaling Pathway WP3888,0.02476220183973203,1.264899692659433,4.678151708032272,"['RPL5', 'ARPC5L', 'RPL10A', 'ELK1', 'RPL7', 'ACTG1', 'TUBB8', 'RPS6KA5', 'RPL18A', 'CFL1', 'ATP6V1E1', 'RPS11', 'IER5', 'TMSB10', 'MAP2K1', 'IGFBP3', 'PRKCD', 'RPS6', 'SARS', 'INPP4B', 'RAB37', 'KATNAL2', 'FSCN1', 'PRKD2', 'RPL27', 'PRKD1', 'RPL26', 'ATP6V0D1', 'DSC1', 'ATF4', 'LRRC59', 'SET', 'CNP', 'EPB41', 'NOTCH4', 'PXN', 'FOXO4', 'TXN', 'ACACB', 'NDRG1', 'FUT1', 'ACACA', 'STIP1', 'LDHA', 'PGK1', 'ABL1', 'FADD', 'EGR1', 'JUN', 'JAG1', 'SDF2L1', 'EGR3', 'FN1', 'NFKB1', 'NR4A1', 'CYP2C8', 'NR4A3', 'P4HA2', 'NOX4', 'CYCS', 'HYOU1', 'CALR', 'EIF4G2', 'EIF4G1', 'YWHAE', 'LDB2', 'SHB', 'HERPUD1', 'RND1', 'CSRP2', 'TMSB4X', 'RACK1', 'RPLP2', 'SH3BGRL3', 'ELOC', 'RAC1', 'ACP1', 'HRAS', 'DUSP5', 'HSP90AA1', 'ANXA1', 'SSR4', 'GAB1', 'RPL13A', 'EPN1', 'VAV2', 'RCN1', 'ALDOA', 'GAPDH', 'SLC25A11', 'PTMA', 'FJX1', 'ARF6', 'KANK1', 'CRIP2', 'HDAC9', 'APOLD1', 'PPP2CA', 'AP2S1', 'DNAJB9', 'FLNB', 'ASCC3', 'CCT7', 'ABCF2', 'MAPK3', 'STAT1', 'SOD2', 'TPCN2', 'RAB11A', 'DNAJA1', 'PTPN9', 'P4HB', 'EIF3D']",0.5392657289541642,0,0,113
28,Calcium Regulation in the Cardiac Cell WP536,0.025783081350348035,1.4976803543277533,5.478569796514002,"['CHRM2', 'RYR1', 'YWHAE', 'GNAZ', 'RYR2', 'CHRM1', 'RGS19', 'RGS14', 'YWHAB', 'CHRM5', 'CACNA1B', 'CACNA1A', 'ITPR2', 'ATP2A2', 'ADRB1', 'ADRA1D', 'CACNA1C', 'RGS4', 'GNG3', 'PLN', 'GRK5', 'YWHAQ', 'RGS20', 'YWHAG', 'YWHAH', 'PRKCG', 'PRKCH', 'PRKCD', 'ATP1B1', 'FKBP1A', 'SLC8A3', 'ADCY9', 'PRKAR1A', 'PRKCQ', 'CALM3', 'PRKD1', 'CALR', 'CASQ1', 'CAMK1', 'CALM1', 'CALM2']",0.5414447083573087,0,0,41
29,Vitamin D Receptor Pathway WP2877,0.028805414401581683,1.649526920477585,5.8511885467464975,"['COLEC11', 'CEBPA', 'CDKN1A', 'ABCB1', 'CDKN1B', 'HILPDA', 'CLEC16A', 'EFNA5', 'CYP3A5', 'CREG2', 'TIMP2', 'TIMP3', 'SOSTDC1', 'CDKN2D', 'SERPINB1', 'TGFB1', 'CDKN2C', 'IGFBP5', 'GADD45A', 'CDKN2A', 'IGFBP3', 'MYO9B', 'CEACAM1', 'TNFSF4', 'S100A6', 'PRKCQ', 'CLPTM1L']",0.584054609245863,0,0,27
30,Aryl Hydrocarbon Receptor Pathway WP2873,0.030599051127004322,2.3750495922415693,8.281290331184257,"['HSP90AA1', 'JUN', 'CDKN1B', 'TGFB1', 'JUND', 'CDC37', 'MGST1', 'AIP', 'CYP1B1', 'AHRR', 'BAX']",0.5997414020892847,0,0,11
31,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.03213933825529911,2.146788990825688,7.379961788520285,"['PRKCG', 'MAP2K1', 'PRKCH', 'PRKCD', 'PIK3CD', 'NFKB1', 'STAR', 'FSHR', 'PRKCQ', 'AMH', 'HRAS', 'PLCB2', 'MAPK3']",0.609610674003738,0,0,13
32,Blood Clotting Cascade WP272,0.033752030439897523,4.674866514111366,15.841788887617344,"['F8A1', 'VWF', 'F12', 'KLKB1', 'F5']",0.620193559333117,0,0,5
33,Methionine De Novo and Salvage Pathway WP3580,0.036207447521723335,2.805897509304323,9.311344084562617,"['MSRA', 'AHCY', 'CHDH', 'AMD1', 'ODC1', 'TXN', 'MAT2B', 'SRM']",0.645150883114343,0,0,8
34,Monoamine GPCRs WP58,0.03913523716574064,2.5255154639175257,8.184518809578186,"['CHRM2', 'HRH1', 'CHRM1', 'HTR1E', 'CHRM5', 'ADRB1', 'ADRA1D', 'HTR5A', 'ADRA2C']",0.6768093956898675,0,0,9
35,Glycolysis in senescence WP5049,0.043381721952865736,3.3661802575107296,10.562121287493364,"['LDHA', 'PKM', 'PGK1', 'ALDOC', 'ENO1', 'GAPDH']",0.7288129288081444,0,0,6
36,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.0448588475507462,5.608807549327995,17.411053562671874,"['HSD11B1', 'HSD11B2', 'H6PD', 'STAR']",0.7326945099955212,0,0,4
37,Senescence and Autophagy in Cancer WP615,0.04756425878965063,1.5480596383631173,4.714884473262311,"['CDKN1A', 'CEBPB', 'SPARC', 'CDKN1B', 'PCNA', 'ING1', 'GABARAP', 'IGF1R', 'MAP1LC3B', 'ING2', 'MAP1LC3A', 'LAMP1', 'SLC39A1', 'HRAS', 'SLC39A3', 'GABARAPL2', 'GABARAPL1', 'MAP2K1', 'JUN', 'TGFB1', 'GSN', 'IGFBP5', 'CDKN2A', 'IGFBP3', 'FN1', 'HMGA1', 'RSL1D1']",0.7558860586030964,0,0,27
38,Complement and Coagulation Cascades WP558,0.05497517399364354,2.295688847235239,6.6595031193056595,"['CPB2', 'VWF', 'SERPIND1', 'PROS1', 'F12', 'CLU', 'KLKB1', 'F5', 'C2']",0.8258449493679917,0,0,9
39,Development of ureteric collection system WP5053,0.05594749298748479,2.057956064947469,5.933790442757253,"['GRIP1', 'FRAS1', 'GREB1L', 'ANOS1', 'RARB', 'GFRA1', 'SPRY1', 'SLIT2', 'FAT4', 'ETV4', 'ROBO1']",0.8258449493679917,0,0,11
40,miR-517 relationship with ARCN1 and USP1 WP3596,0.05840622029817581,8.411663807890223,23.89192531315506,"['CDKN1A', 'USP1', 'ARCN1']",0.8258449493679917,0,0,3
41,Nucleotide GPCRs WP80,0.05840622029817581,8.411663807890223,23.89192531315506,"['ADORA2A', 'LPAR6', 'LTB4R']",0.8258449493679917,0,0,3
42,Spinal Cord Injury WP2431,0.06733448348177816,1.4902951108500955,4.020939589089232,"['RTN4R', 'BTG2', 'CDKN1B', 'XYLT1', 'RTN4', 'LTB4R', 'TNFSF13B', 'ACAN', 'RAC1', 'SLIT2', 'ROS1', 'MAPK3', 'EGR1', 'TGFB1', 'ANXA1', 'GADD45A', 'BDNF', 'OMG', 'MIF', 'FOS', 'RHOB', 'SELP', 'FKBP1A', 'NR4A1', 'APEX1', 'NOX4']",0.8258449493679917,0,0,26
43,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.06735631676062663,1.6164865194158704,4.360890394121,"['RYR2', 'ITGA4', 'LAMA2', 'TCF7', 'CACNA2D3', 'ATP2A2', 'CACNA1C', 'ACTB', 'ACTG1', 'SGCD', 'ITGA10', 'LMNA', 'PKP2', 'CTNNA3', 'CTNNA2', 'CACNG2', 'EMD', 'SGCG', 'ITGA9']",0.8258449493679917,0,0,19
44,Galanin receptor pathway WP4970,0.06787420961534081,2.8048640915593706,7.5453624959625465,"['CDKN1A', 'CDKN1B', 'BCL2L11', 'PRKCD', 'PPARG', 'FOS']",0.8258449493679917,0,0,6
45,Gastric acid production WP2596,0.06917277474675686,inf,inf,"['CCK', 'MUC6']",0.8258449493679917,0,0,2
46,MED and Pseudoachondroplasia genes WP4789,0.06917277474675686,inf,inf,"['MATN1', 'COL9A3']",0.8258449493679917,0,0,2
47,Nanomaterial-induced inflammasome activation WP3890,0.06917277474675686,inf,inf,"['NFKB1', 'CTSB']",0.8258449493679917,0,0,2
48,Ferroptosis WP4313,0.06919834098565548,1.8242115825688074,4.872064875047781,"['PRNP', 'GPX4', 'NCOA4', 'ACSL5', 'SAT2', 'SLC7A11', 'MAP1LC3B', 'TF', 'MAP1LC3A', 'FTH1', 'PCBP1', 'VDAC2', 'FTL']",0.8258449493679917,0,0,13
49,Gastrin signaling pathway WP4659,0.07316322469656392,1.4282993715482766,3.735091952646832,"['CDKN1A', 'CDKN1B', 'PXN', 'PIK3R3', 'ELK1', 'KAT5', 'RAC1', 'JAK2', 'HRAS', 'MEF2D', 'MAPK3', 'EGR1', 'MAP2K1', 'JUN', 'PRKCH', 'JAG1', 'CDKN2A', 'BAD', 'RPS6', 'PRKCD', 'FOS', 'NFKB1', 'RHOB', 'TJP1', 'PRKD2', 'PRKCQ', 'PPARG', 'PRKD1', 'SOS1', 'LAMTOR3']",0.8258449493679917,0,0,30
50,Photodynamic therapy-induced unfolded protein response WP3613,0.07388222830097455,2.004133076891599,5.221333760852006,"['NARS', 'XBP1', 'BCL2L11', 'WARS', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR', 'HSP90B1', 'ATF4']",0.8258449493679917,0,0,10
51,Zinc homeostasis WP3529,0.07402933519636849,2.244259948468365,5.842468105399879,"['SLC30A3', 'SLC39A6', 'SLC39A11', 'SLC30A1', 'SLC39A7', 'SLC30A10', 'SLC39A1', 'SLC39A3']",0.8258449493679917,0,0,8
52,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.07443840530017612,2.1041666666666665,5.466168964079185,"['FZD1', 'ADAMTS2', 'P4HA1', 'P4HA2', 'SERPINF1', 'P3H2', 'PLOD2', 'P4HB', 'PPIB']",0.8258449493679917,0,0,9
53,White fat cell differentiation WP4149,0.07443840530017612,2.1041666666666665,5.466168964079185,"['CEBPA', 'CEBPB', 'EGR2', 'KLF5', 'DDIT3', 'RORA', 'PPARG', 'ZNF423', 'KLF15']",0.8258449493679917,0,0,9
54,Apoptosis Modulation and Signaling WP1772,0.07763366063814142,1.501919039276783,3.838535854744695,"['JUN', 'ENDOG', 'CRADD', 'CDKN2A', 'BAD', 'TRADD', 'BNIP3', 'HTRA2', 'FOS', 'NFKB1', 'BCL2L11', 'CAPNS1', 'IRAK1', 'CASP6', 'TRAF3', 'TOLLIP', 'PEA15', 'CYCS', 'BAX', 'PRKD1', 'FADD', 'BCL2L2', 'MAPK3']",0.8453443047264289,0,0,23
55,Dual hijack model of Vif in HIV infection WP3300,0.08316185594183594,3.738823753693642,9.298329419301147,"['UBB', 'ELOB', 'ELOC', 'RUNX1']",0.8660408999383581,0,0,4
56,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.08316185594183594,3.738823753693642,9.298329419301147,"['JUN', 'IRAK1', 'UBE2N', 'NFKB1']",0.8660408999383581,0,0,4
57,IL-18 signaling pathway WP4754,0.08395294438177961,1.2696287279367011,3.1455036791517816,"['BTG2', 'CD81', 'ENO1', 'RND2', 'PTMS', 'RPTOR', 'GRM7', 'TMSB4X', 'STMN1', 'TIMP3', 'CD36', 'RPS11', 'TICAM2', 'USP5', 'IMP3', 'PRKCD', 'IL18', 'NDUFC1', 'FOS', 'BPGM', 'ACTA2', 'ARL4D', 'ARF6', 'MYH7', 'CEBPB', 'NRN1', 'STOML1', 'EPB41', 'TSHZ1', 'MEPCE', 'COX17', 'ACACB', 'FUT1', 'CENPB', 'IRAK1', 'FADD', 'ABCF1', 'MAPK3', 'CA11', 'SLC12A3', 'JUN', 'BAD', 'FN1', 'DEK', 'EEF2', 'NFKB1', 'NR4A1', 'TF', 'CCDC9', 'NACA', 'CYCS', 'BAX', 'NFKBIE', 'CDK5R2', 'AARS', 'ITM2C']",0.8660408999383581,0,0,56
58,Melanoma WP4685,0.08545556985348159,1.511715296198055,3.718454835028462,"['CDKN1A', 'MAP2K1', 'GADD45B', 'CDKN2A', 'BAD', 'GADD45A', 'PIK3CD', 'PIK3R3', 'MITF', 'FOS', 'ELK1', 'GRM3', 'BAX', 'CALM3', 'RAC1', 'SOS1', 'CALM1', 'HRAS', 'LAMTOR3', 'CALM2', 'MAPK3']",0.8663426736870201,0,0,21
59,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.09761725751723652,1.9421094369547978,4.518707934831904,"['PPP2CA', 'CDKN1A', 'MAP2K1', 'RBL1', 'THRA', 'CNP', 'STAT1', 'PTH1R', 'MAPK3']",0.9526201126653513,0,0,9
60,TP53 network WP1742,0.09882623617786808,2.4039239730226853,5.563622799094677,"['CDKN1A', 'SUMO1', 'CDKN2A', 'GADD45A', 'ABL1', 'BAX']",0.9526201126653513,0,0,6
61,Tryptophan catabolism leading to NAD+ production WP4210,0.09882623617786808,2.4039239730226853,5.563622799094677,"['NMNAT1', 'TDO2', 'HAAO', 'NMNAT3', 'KMO', 'NADSYN1']",0.9526201126653513,0,0,6
62,"GPCRs, Other WP117",0.10518904415723854,1.6580353419516263,3.733889168659731,"['CHRM2', 'ADGRV1', 'GPR88', 'OR2M4', 'ADRA1D', 'GPR83', 'CELSR2', 'RXFP1', 'GPR162', 'ADORA2A', 'FSHR', 'ADGRF5', 'GPR135']",0.9817644121342264,0,0,13
63,IL-3 signaling pathway WP286,0.10518904415723854,1.6580353419516263,3.733889168659731,"['MAP2K1', 'JUN', 'TGFB1', 'YWHAB', 'BAD', 'PIK3CD', 'FOS', 'GAB2', 'YWHAQ', 'JAK2', 'SOS1', 'HRAS', 'MAPK3']",0.9817644121342264,0,0,13
64,Nuclear receptors WP170,0.11966084471408601,1.753258378688055,3.7223320492738132,"['NR4A1', 'AR', 'THRA', 'RARB', 'RORA', 'NR1D2', 'ROR1', 'PPARG', 'PPARA', 'NR2F6']",0.9999830567881718,0,0,10
65,G1 to S cell cycle control WP45,0.12167815673632244,1.4908241245694605,3.1402358276337305,"['CDKN2D', 'CDKN1A', 'CDKN1B', 'PCNA', 'CDKN2C', 'CDKN2A', 'GADD45A', 'RPA2', 'CREB3', 'CCNE2', 'TFDP2', 'RPA3', 'POLE2', 'CCNG2', 'MCM3', 'MCM4', 'MCM6']",0.9999830567881718,0,0,17
66,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.12446921270975293,1.8032032400589102,3.75732896735395,"['FGD4', 'EGR2', 'RAB3A', 'NEFL', 'MFN2', 'RABAC1', 'NDRG1', 'RAB11A', 'DNM2']",0.9999830567881718,0,0,9
67,PI3K-Akt signaling pathway WP4172,0.13150985386748235,1.2015682185077858,2.437589598304331,"['CHRM2', 'CDKN1A', 'CDKN1B', 'CHRM1', 'FLT3', 'PIK3CD', 'FGF1', 'IGF1R', 'RPTOR', 'GYS2', 'GYS1', 'TNR', 'RAC1', 'JAK2', 'HRAS', 'IFNAR2', 'PDGFRA', 'MAP2K1', 'HSP90AA1', 'VWF', 'ITGA4', 'RPS6', 'CREB3', 'CCNE2', 'CDC37', 'DDIT4', 'COL6A6', 'SOS1', 'ATF4', 'ITGA9', 'LAMA2', 'LAMA4', 'LAMA3', 'PIK3R3', 'EFNA5', 'THBS4', 'HSP90B1', 'PPP2CA', 'PPP2CB', 'GNG10', 'GNG3', 'BCL2L11', 'PDGFD', 'EIF4B', 'MAPK3', 'ANGPT2', 'LAMB3', 'BDNF', 'EGF', 'BAD', 'FN1', 'VEGFD', 'NFKB1', 'FGF17', 'EFNA3', 'FGF14', 'LPAR6', 'IL7', 'ITGA10', 'COL9A3', 'FGF12', 'FGF10']",0.9999830567881718,0,0,62
68,IL1 and megakaryocytes in obesity WP2865,0.13257170845262833,2.8038318558764654,5.6655112044354095,"['IRAK1', 'IL18', 'TIMP2', 'NFKB1']",0.9999830567881718,0,0,4
69,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.1330273574901521,1.9631654264453349,3.960098233670139,"['EIF5', 'EIF1AX', 'EIF3I', 'EIF3G', 'EIF3CL', 'EIF3D', 'EIF1']",0.9999830567881718,0,0,7
70,MAPK pathway in congenital thyroid cancer WP4928,0.1359031608339375,2.1032188841201718,4.19763095889753,"['MAP2K1', 'JUN', 'FOS', 'SOS1', 'ELK1', 'MAPK3']",0.9999830567881718,0,0,6
71,GDNF/RET signaling axis WP4830,0.13655276723464388,2.336718154080854,4.6525090480579605,"['EYA1', 'GFRA1', 'SPRY1', 'SLIT2', 'FAT4']",0.9999830567881718,0,0,5
72,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.13655276723464388,2.336718154080854,4.6525090480579605,"['CDK8', 'JAG1', 'CSRP2', 'TULP3', 'SOX4']",0.9999830567881718,0,0,5
73,Hypertrophy Model WP516,0.13655276723464388,2.336718154080854,4.6525090480579605,"['JUND', 'NR4A3', 'ZEB1', 'WDR1', 'IL18']",0.9999830567881718,0,0,5
74,RalA downstream regulated genes WP2290,0.13655276723464388,2.336718154080854,4.6525090480579605,"['EXOC8', 'RAC3', 'RAC1', 'YBX3', 'HRAS']",0.9999830567881718,0,0,5
75,Base Excision Repair WP4752,0.14008130507997493,1.6240386065450159,3.1921002959902522,"['POLE4', 'POLD4', 'FEN1', 'PCNA', 'NEIL2', 'MPG', 'APEX1', 'POLE2', 'POLD2', 'POLE3', 'APEX2']",0.9999830567881718,0,0,11
76,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.1532413240630611,1.2690903919988623,2.380485285480258,"['CHRM2', 'YWHAE', 'RYR2', 'CEBPB', 'YWHAB', 'ATP1A3', 'RORA', 'HDAC9', 'HSP90B1', 'NEUROD1', 'YWHAQ', 'PKNOX1', 'SCN3B', 'YWHAG', 'YWHAH', 'CHRNB2', 'EGR1', 'GABRA1', 'JUN', 'TSPYL1', 'CAV3', 'BDNF', 'SSTR1', 'NFKB1', 'GCK', 'ADCYAP1', 'AR', 'TF', 'PRKAR1A', 'BHLHE40', 'ALDOA', 'GAPDH', 'SLC25A4']",0.9999830567881718,0,0,33
77,Adipogenesis WP236,0.1534542348764421,1.2921238387828249,2.421896065074421,"['CEBPA', 'CDKN1A', 'CEBPB', 'ASIP', 'LPL', 'RORA', 'AGPAT2', 'CYP26B1', 'LMNA', 'NDN', 'SPOCK1', 'MEF2D', 'FZD1', 'GDF10', 'WWTR1', 'EGR2', 'TGFB1', 'GADD45B', 'GADD45A', 'STAT1', 'HMGA1', 'MIF', 'KLF15', 'BSCL2', 'RBL1', 'KLF5', 'DDIT3', 'PPARG', 'PPARA']",0.9999830567881718,0,0,29
78,Cell migration and invasion through p75NTR WP4561,0.15482141041041647,1.6828178694158076,3.1392681565127263,"['ARF1', 'JUN', 'EFNA3', 'EFNB3', 'BDNF', 'PARD3', 'CDH11', 'RAC1', 'EFNA5']",0.9999830567881718,0,0,9
79,7q11.23 copy number variation syndrome WP4932,0.16135250426704512,1.2883650455740536,2.350188928716476,"['PCNA', 'ATP5MC2', 'ATP5MC3', 'UBE2L6', 'ACACB', 'ACACA', 'ATP5MC1', 'GRIP1', 'ATP5F1B', 'CFL1', 'BCL7B', 'EIF4H', 'WNT2', 'MAPK3', 'ATP5PB', 'H2AFX', 'HMGA1', 'NRG1', 'DEK', 'ATP5F1D', 'ATP5F1E', 'MLXIPL', 'DNAJC30', 'ATP5PO', 'GTF2IRD1', 'GAPDH', 'ATF4', 'FBN1']",0.9999830567881718,0,0,28
80,Oxidative Damage WP3941,0.16805798283499132,1.5426790830945558,2.7512851843577297,"['CDKN1A', 'PCNA', 'CDKN1B', 'MAP3K1', 'BAD', 'GADD45A', 'TRAF3', 'CYCS', 'NFKBIE', 'NFKB1', 'C2']",0.9999830567881718,0,0,11
81,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.17057156146811456,1.7845137118176615,3.156091584149752,"['H3F3B', 'H2AFZ', 'H3F3A', 'H2AFX', 'DUSP6', 'MAPK3', 'EZH2']",0.9999830567881718,0,0,7
82,TYROBP causal network in microglia WP3945,0.17057156146811456,1.7845137118176615,3.156091584149752,"['RBM47', 'IGSF6', 'ADAP2', 'IL18', 'LHFPL2', 'SAMSN1', 'TGFBR1']",0.9999830567881718,0,0,7
83,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.17420697483506498,1.1703235493558075,2.0451534821855315,"['CHRM2', 'CDKN1A', 'CDKN1B', 'CHRM1', 'SLC2A1', 'PIK3CD', 'SLC2A3', 'FGF1', 'IGF1R', 'RPTOR', 'GYS2', 'GYS1', 'TNR', 'JAK2', 'PELO', 'HRAS', 'IFNAR2', 'PDGFRA', 'MAP2K1', 'HSP90AA1', 'VWF', 'ITGA4', 'RPS6', 'CREB3', 'CDC37', 'DDIT4', 'SOS1', 'ATF4', 'ITGA9', 'PFKFB4', 'LAMA2', 'COL11A1', 'LAMA4', 'LAMA3', 'EFNA5', 'ACACA', 'THBS4', 'HSP90B1', 'PPP2CA', 'PPP2CB', 'GNG10', 'GNG3', 'PDGFD', 'EIF4B', 'MAPK3', 'ANGPT2', 'LAMB3', 'EGF', 'BAD', 'FN1', 'VEGFD', 'FGF17', 'EFNA3', 'FGF14', 'RAB14', 'LPAR6', 'ITGA10', 'COL5A2', 'FGF12', 'FGF10']",0.9999830567881718,0,0,60
84,Aryl Hydrocarbon Receptor Netpath WP2586,0.17642128287633144,1.4586238532110092,2.5305380673152365,"['CDKN1A', 'HSP90AA1', 'MAP2K1', 'CDKN1B', 'AIP', 'LPL', 'NFKB1', 'PSRC1', 'CDC37', 'CYP1B1', 'AHRR', 'CD36', 'HRAS']",0.9999830567881718,0,0,13
85,PDGF Pathway WP2526,0.17642128287633144,1.4586238532110092,2.5305380673152365,"['MAP2K1', 'JUN', 'MAP3K1', 'STAT1', 'FOS', 'ELK1', 'NFKB1', 'VAV2', 'ARFIP2', 'RAC1', 'SOS1', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,13
86,TGF-beta Receptor Signaling WP560,0.17642128287633144,1.4586238532110092,2.5305380673152365,"['JUN', 'TGFB1', 'STAT1', 'EGF', 'FOS', 'LTBP1', 'TGFBR1', 'NFKB1', 'TGFBR3', 'FKBP1A', 'ZNF423', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,13
87,Prolactin Signaling Pathway WP2037,0.17706347128421676,1.3360966334249873,2.3131133095202507,"['MAP2K1', 'JUN', 'STAT1', 'RPS6', 'PXN', 'FOS', 'GAB2', 'ELK1', 'NFKB1', 'VAV2', 'TEC', 'RPS6KA2', 'RAC1', 'JAK2', 'SOS1', 'PPIB', 'CTSD', 'HRAS', 'YWHAG', 'MAPK3']",0.9999830567881718,0,0,20
88,PDGFR-beta pathway WP3972,0.1778417590763766,1.558133613418632,2.690680353712066,"['MAP2K1', 'JUN', 'MAP3K1', 'STAT1', 'FOS', 'JAK2', 'SOS1', 'ELK1', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,10
89,Kynurenine Pathway and links to Cellular Senescence WP5044,0.17841782659946692,1.8693371483071053,3.2220402406573445,"['CDKN1A', 'KLF5', 'TDO2', 'HAAO', 'KMO', 'ACMSD']",0.9999830567881718,0,0,6
90,Hepatitis B infection WP4666,0.18208630559234698,1.2280546739757645,2.0917142080309876,"['CDKN1A', 'PCNA', 'YWHAB', 'PIK3R3', 'PIK3CD', 'ELK1', 'IFIH1', 'IRAK1', 'YWHAQ', 'FADD', 'JAK2', 'HRAS', 'MAPK3', 'PRKCG', 'MAP2K1', 'JUN', 'EGR2', 'TICAM2', 'TGFB1', 'EGR3', 'MAP3K1', 'ATP6AP1', 'SLC10A1', 'STAT1', 'BAD', 'NFATC3', 'FOS', 'NFKB1', 'TGFBR1', 'CREB3', 'TRAF3', 'CYCS', 'BAX', 'SOS1', 'ATF4']",0.9999830567881718,0,0,35
91,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.18560888999302316,2.0026969597907813,3.3727691087730887,"['CD63', 'EGF', 'CD81', 'ETS2', 'SOD1']",0.9999830567881718,0,0,5
92,Major receptors targeted by epinephrine and norepinephrine WP4589,0.18560888999302316,2.0026969597907813,3.3727691087730887,"['ADCY10', 'ADCY9', 'ADRB1', 'ADRA1D', 'ADRA2C']",0.9999830567881718,0,0,5
93,Complement system WP2806,0.1870104682081531,1.4633818086657444,2.4534923075025166,"['SELP', 'PRNP', 'FKBP2', 'RPS19', 'PROS1', 'F12', 'APOA1', 'CD59', 'TXN', 'CALR', 'KLKB1', 'C2']",0.9999830567881718,0,0,12
94,ACE Inhibitor Pathway WP554,0.19053748279141333,2.8033161806746714,4.647635679365961,"['MAS1', 'TGFB1', 'ATP6AP2']",0.9999830567881718,0,0,3
95,EDA signaling in hair follicle development WP3930,0.19053748279141333,2.8033161806746714,4.647635679365961,"['PTCH1', 'SOSTDC1', 'RELB']",0.9999830567881718,0,0,3
96,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.19053748279141333,2.8033161806746714,4.647635679365961,"['CEBPB', 'ALDH1A1', 'ADH5']",0.9999830567881718,0,0,3
97,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.19053748279141333,2.8033161806746714,4.647635679365961,"['AHCY', 'ADK', 'MAT2B']",0.9999830567881718,0,0,3
98,Tamoxifen metabolism WP691,0.19053748279141333,2.8033161806746714,4.647635679365961,"['CYP2C8', 'CYP1B1', 'CYP3A5']",0.9999830567881718,0,0,3
99,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.19261560643684097,1.4024949813593346,2.3099916345189877,"['JUN', 'TGFB1', 'STAT1', 'EGF', 'FOS', 'LTBP1', 'TGFBR1', 'NFKB1', 'TGFBR3', 'FKBP1A', 'ZNF423', 'HRAS', 'MAPK3', 'FBN1']",0.9999830567881718,0,0,14
100,Pyrimidine metabolism WP4022,0.1980346860710754,1.2705813404528954,2.0574689856455364,"['DPYS', 'NME2', 'NME3', 'DCK', 'NME1', 'NT5C', 'POLE4', 'POLD4', 'ZNRD1', 'POLR2C', 'POLE2', 'POLD2', 'POLE3', 'POLR2E', 'ENPP1', 'POLR1E', 'CMPK2', 'POLR3H', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'POLR2L']",0.9999830567881718,0,0,24
101,DNA Mismatch Repair WP531,0.19976699664949643,1.602388450370128,2.580812620138363,"['POLE4', 'POLD4', 'PCNA', 'RPA3', 'POLE2', 'POLD2', 'POLE3', 'RPA2']",0.9999830567881718,0,0,8
102,Metabolic reprogramming in colon cancer WP4290,0.20437708411702948,1.4023795871559632,2.2266822370311905,"['MDH2', 'PGAM1', 'GOT2', 'SLC2A1', 'PYCR2', 'PDHB', 'ENO1', 'ACLY', 'LDHA', 'PKM', 'PGK1', 'ALDOB', 'GAPDH']",0.9999830567881718,0,0,13
103,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.21103146212271495,1.4759758175157172,2.296246495571663,"['MAP2K1', 'TEC', 'STAT1', 'TNFSF4', 'RPS6', 'GAB2', 'JAK2', 'NFKB1', 'RELB', 'MAPK3']",0.9999830567881718,0,0,10
104,Vitamin A and carotenoid metabolism WP716,0.21103146212271495,1.4759758175157172,2.296246495571663,"['ABCG8', 'CYP26B1', 'RBP4', 'RDH12', 'RBP2', 'ALDH1A1', 'LPL', 'RARB', 'CD36', 'BCO1']",0.9999830567881718,0,0,10
105,Canonical and non-canonical Notch signaling WP3845,0.21208429892528416,1.6356372829612669,2.536499595912098,"['JAG1', 'MAML2', 'HEY1', 'CNTN6', 'NOTCH4', 'DLL3', 'DLK2']",0.9999830567881718,0,0,7
106,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.21208429892528416,1.6356372829612669,2.536499595912098,"['LDHA', 'RPS6', 'SLC2A1', 'KEAP1', 'PDHB', 'ACACB', 'ACACA']",0.9999830567881718,0,0,7
107,Glycogen Synthesis and Degradation WP500,0.21716883593640743,1.4022642591000287,2.1413699602404583,"['PPP2CA', 'GYS2', 'PPP2CB', 'GYS1', 'GSK3A', 'GBE1', 'PHKA1', 'CALM3', 'GYG2', 'CALM1', 'PHKA2', 'CALM2']",0.9999830567881718,0,0,12
108,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.22172700261861347,1.3199426111908177,1.9882406054894681,"['FZD1', 'CDKN1A', 'MAP2K1', 'JUN', 'CDKN1B', 'FN1', 'ELK1', 'SOD1', 'PPP2CA', 'TMSB4X', 'NEFL', 'NEFM', 'CAMK1', 'SOS1', 'NEFH', 'PFN2']",0.9999830567881718,0,0,16
109,Endometrial cancer WP4155,0.22189398680678246,1.2946398992910622,1.9491522831347219,"['CDKN1A', 'MAP2K1', 'GADD45B', 'BAD', 'EGF', 'GADD45A', 'TCF7', 'PIK3CD', 'PIK3R3', 'FOS', 'FGF1', 'ELK1', 'BAX', 'CTNNA3', 'CTNNA2', 'SOS1', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,18
110,Alpha 6 Beta 4 signaling pathway WP244,0.22476589138734288,1.4845360824742269,2.215960925460949,"['LAMA2', 'LAMB3', 'LAMA3', 'PRKCD', 'GAB1', 'RAC1', 'SOS1', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,9
111,Folate Metabolism WP176,0.22476589138734288,1.4845360824742269,2.215960925460949,"['SLC46A1', 'AHCY', 'GPX4', 'GPX3', 'RFK', 'APOA1', 'SOD2', 'NFKB1', 'SOD1']",0.9999830567881718,0,0,9
112,Oxidation by Cytochrome P450 WP43,0.22476589138734288,1.4845360824742269,2.215960925460949,"['CYP27A1', 'CYP39A1', 'CYP26B1', 'CYP2C8', 'CYP3A43', 'CYP1B1', 'CYP3A5', 'CYP2C18', 'CYP3A7']",0.9999830567881718,0,0,9
113,Microglia Pathogen Phagocytosis Pathway WP3937,0.22542540420028118,1.6822317596566523,2.5061316401897606,"['VAV3', 'PIK3R3', 'PIK3CD', 'RAC3', 'RAC1', 'VAV2']",0.9999830567881718,0,0,6
114,Proteoglycan biosynthesis WP4784,0.22542540420028118,1.6822317596566523,2.5061316401897606,"['EXT1', 'CANT1', 'B3GAT3', 'XYLT1', 'B3GALT6', 'B4GALT7']",0.9999830567881718,0,0,6
115,p38 MAPK Signaling Pathway WP400,0.23114644222405434,1.4021489971346706,2.053732992731926,"['RPS6KA5', 'MAP3K1', 'STAT1', 'TRADD', 'DDIT3', 'RAC1', 'ELK1', 'HRAS', 'MEF2D', 'TGFBR1', 'HMGN1']",0.9999830567881718,0,0,11
116,Type 2 papillary renal cell carcinoma WP4241,0.23114644222405434,1.4021489971346706,2.053732992731926,"['CDKN1A', 'EGLN3', 'TGFB1', 'EGLN2', 'CADM2', 'CTSK', 'SLC2A1', 'TFEB', 'COL21A1', 'ELOB', 'ELOC']",0.9999830567881718,0,0,11
117,Prader-Willi and Angelman Syndrome WP3998,0.2341445087271986,1.3503015630309207,1.9603904882955134,"['PCSK1', 'OCA2', 'MAGEL2', 'SLC45A2', 'CDKN2C', 'CDKN2A', 'BDNF', 'TYR', 'GABRG3', 'FEZ1', 'NDN', 'GHRL', 'GABRD']",0.9999830567881718,0,0,13
118,Oncostatin M Signaling Pathway WP2374,0.23487643590525586,1.2887020200453037,1.866937085047316,"['EGR1', 'MAP2K1', 'CEBPB', 'CDKN1B', 'PRKCH', 'JUND', 'STAT1', 'PRKCD', 'RPS6', 'PXN', 'FOS', 'NFKB1', 'TIMP3', 'JAK2', 'SOS1', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,17
119,Fatty acid transporters WP5061,0.23984805029590905,1.7521810640732265,2.5016759533831103,"['FABP5', 'FABP6', 'FABP7', 'ACSL5', 'CD36']",0.9999830567881718,0,0,5
120,Type II diabetes mellitus WP1584,0.23984805029590905,1.7521810640732265,2.5016759533831103,"['SURF1', 'KCNJ11', 'PRKCD', 'CACNA1A', 'PHKA2']",0.9999830567881718,0,0,5
121,Oxidative Stress WP408,0.23992581488841758,1.495409867353755,2.1345861896570306,"['GPX3', 'MGST1', 'NOX4', 'FOS', 'SOD2', 'NFKB1', 'TXN2', 'SOD1']",0.9999830567881718,0,0,8
122,Ebola Virus Pathway on Host WP4217,0.24542176661390197,1.2023192696767826,1.6889905193764245,"['VPS4A', 'PIK3R3', 'PIK3CD', 'ACTB', 'ASGR1', 'IGF1R', 'ACTG1', 'RELB', 'CLTCL1', 'FLNB', 'RAC1', 'CTSB', 'MAPK3', 'VPS18', 'GSN', 'CAV3', 'ITGA4', 'CAV2', 'STAT1', 'HLA-C', 'MERTK', 'NFKB1', 'TPCN2', 'RHOB', 'VAV2', 'TYRO3', 'HLA-DQB1']",0.9999830567881718,0,0,27
123,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.24650653998268676,1.4020338012030937,1.9633615238640205,"['LDHA', 'ANGPT2', 'PKM', 'IGFBP3', 'BNIP3', 'IGFBP2', 'SLC2A1', 'PGK1', 'BAX', 'SLC2A3']",0.9999830567881718,0,0,10
124,Synaptic Vesicle Pathway WP2267,0.24967918830389957,1.3087276550998947,1.8159622675399538,"['NSF', 'RAB3A', 'CACNA1B', 'CACNA1A', 'PARK7', 'SYP', 'SYN3', 'DNM2', 'RIMS1', 'CLTCL1', 'AP2S1', 'SLC25A4', 'SLC18A2', 'AP2M1']",0.9999830567881718,0,0,14
125,Nuclear Receptors Meta-Pathway WP2882,0.2523795197077349,1.126790396990481,1.5513890122384566,"['CDKN1B', 'SRXN1', 'SLC2A1', 'KEAP1', 'SLC2A3', 'GCC1', 'SLC7A11', 'CPT2', 'FTH1', 'ENC1', 'SLC39A6', 'CYP1B1', 'SLC39A7', 'SLC39A1', 'SLC39A3', 'ABCG8', 'HSP90AA1', 'SLC6A16', 'GPX3', 'TSC22D3', 'SLC2A12', 'SLC39A11', 'AIP', 'APOA1', 'NRG1', 'TGFBR3', 'KAT2B', 'SLC5A8', 'CDC37', 'AHRR', 'PPARA', 'FKBP5', 'FTL', 'ABCB1', 'GSTP1', 'AMIGO2', 'MGST1', 'TXN', 'CYP3A5', 'CYP3A7', 'FGD4', 'PRDX1', 'EGR1', 'GSTM3', 'JUN', 'JUND', 'TGFB1', 'GADD45B', 'SLC10A1', 'PLK2', 'SLC2A9', 'PSMC5', 'BHLHE40', 'BAX', 'SPRY1']",0.9999830567881718,0,0,55
126,Development and heterogeneity of the ILC family WP3893,0.2552723238013436,1.868839958059289,2.551759617105664,"['IL7', 'IL18', 'RORA', 'TOX']",0.9999830567881718,0,0,4
127,Dopamine metabolism WP2436,0.2552723238013436,1.868839958059289,2.551759617105664,"['PPP2CA', 'PPP2CB', 'TYR', 'SOD1']",0.9999830567881718,0,0,4
128,Dopaminergic Neurogenesis WP2855,0.2552723238013436,1.868839958059289,2.551759617105664,"['NEUROD1', 'TGFB1', 'ALDH1A1', 'SLC18A2']",0.9999830567881718,0,0,4
129,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.2552723238013436,1.868839958059289,2.551759617105664,"['GRM3', 'GABBR1', 'GRM4', 'GRM7']",0.9999830567881718,0,0,4
130,Osteoclast Signaling WP12,0.2552723238013436,1.868839958059289,2.551759617105664,"['AIMP2', 'ATP6V1G1', 'GPR68', 'CTSK']",0.9999830567881718,0,0,4
131,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.2588415692896658,1.2392904371986162,1.6749494896062243,"['PRKN', 'HSPA8', 'HSPA1L', 'HSPA5', 'TUBB', 'UBE2L6', 'TUBB4B', 'TUBA4A', 'PSMD8', 'TUBB8', 'PSMC5', 'TUBA1A', 'PSMD7', 'TUBB2A', 'PSMC3', 'PSMD2', 'PSMC1', 'PSMD3', 'STUB1']",0.9999830567881718,0,0,19
132,Proteasome Degradation WP183,0.2616587275362025,1.2546604024412351,1.6821410063811486,"['H2AFZ', 'H2AFX', 'HLA-C', 'PSMB10', 'PSMA7', 'PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'PSMB5', 'UBB', 'PSMC3', 'PSMD2', 'PSMC1', 'PSMD3', 'UBC', 'PSME1']",0.9999830567881718,0,0,17
133,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.26303508809027915,inf,inf,['FMO5'],0.9999830567881718,0,0,1
134,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.2635038016471297,1.401918671248568,1.869721384871401,"['CREB3', 'STAR', 'ITPR2', 'CALM3', 'CAMK1', 'CALM1', 'PLCB2', 'CALM2', 'ATF4']",0.9999830567881718,0,0,9
135,Pathogenic Escherichia coli infection WP2272,0.26549179972415277,1.3019433977719528,1.7266000008181814,"['TUBB', 'ARPC5L', 'ARPC4', 'ARPC5', 'TUBB4B', 'ACTB', 'TUBA4A', 'ACTG1', 'TUBB8', 'TUBA1A', 'TUBB2A', 'YWHAQ', 'ABL1']",0.9999830567881718,0,0,13
136,DNA Replication WP466,0.26567163118785697,1.3410489597608073,1.7775526207661811,"['POLD4', 'PCNA', 'RPA3', 'POLE2', 'UBC', 'POLD2', 'MCM3', 'RPA2', 'MCM4', 'MCM6', 'UBA52']",0.9999830567881718,0,0,11
137,Bile acids synthesis and enterohepatic circulation  WP4389,0.27106920047640876,2.102272727272727,2.7442671659289335,"['ABCG8', 'SLC10A1', 'MAPK3']",0.9999830567881718,0,0,3
138,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.27106920047640876,2.102272727272727,2.7442671659289335,"['LPL', 'APOA1', 'LDLRAP1']",0.9999830567881718,0,0,3
139,Cell cycle WP179,0.27456920538019236,1.1722670838150164,1.515216088096769,"['YWHAE', 'ANAPC13', 'CDKN1A', 'CDKN1B', 'PCNA', 'YWHAB', 'ANAPC10', 'CDC14B', 'ANAPC11', 'YWHAQ', 'ABL1', 'SKP2', 'YWHAG', 'SKP1', 'YWHAH', 'CDKN2D', 'TGFB1', 'CDKN2C', 'GADD45B', 'GADD45A', 'CDKN2A', 'STAG1', 'RBL1', 'CCNE2', 'TFDP2', 'MCM3', 'MCM4', 'MCM6']",0.9999830567881718,0,0,28
140,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.27582433539118545,1.5291455325790089,1.969525808842203,"['TGFBR3', 'ANGPT2', 'LTBP1', 'TGFBR1', 'MAPK3', 'FBN1']",0.9999830567881718,0,0,6
141,Nanomaterial induced apoptosis WP2507,0.27582433539118545,1.5291455325790089,1.969525808842203,"['ENDOG', 'CASP6', 'HTRA2', 'BAX', 'CYCS', 'FADD']",0.9999830567881718,0,0,6
142,Peptide GPCRs WP24,0.28247801349812146,1.4018036072144289,1.7720964219336366,"['OXTR', 'FSHR', 'OPRL1', 'TAC4', 'SSTR1', 'SSTR3', 'TSHR', 'HCRTR2']",0.9999830567881718,0,0,8
143,IL-5 signaling pathway WP127,0.2838629924235567,1.3351338816821487,1.6812854693128594,"['GSK3A', 'MAP2K1', 'JUN', 'STAT1', 'RPS6', 'FOS', 'JAK2', 'SOS1', 'ELK1', 'MAPK3']",0.9999830567881718,0,0,10
144,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.2838819017148388,2.8028008002286366,3.529278264898223,"['TRAF3', 'NFKB1']",0.9999830567881718,0,0,2
145,Cells and molecules involved in local acute inflammatory response  WP4493,0.2838819017148388,2.8028008002286366,3.529278264898223,"['SELP', 'ITGA4']",0.9999830567881718,0,0,2
146,Codeine and Morphine Metabolism WP1604,0.2838819017148388,2.8028008002286366,3.529278264898223,"['CYP2C8', 'ABCB1']",0.9999830567881718,0,0,2
147,Composition of Lipid Particles WP3601,0.2838819017148388,2.8028008002286366,3.529278264898223,"['APOA1', 'LPL']",0.9999830567881718,0,0,2
148,Irinotecan pathway WP229,0.2838819017148388,2.8028008002286366,3.529278264898223,"['ABCC1', 'CYP3A5']",0.9999830567881718,0,0,2
149,Platelet-mediated interactions with vascular and circulating cells WP4462,0.2838819017148388,2.8028008002286366,3.529278264898223,"['SELP', 'TGFB1']",0.9999830567881718,0,0,2
150,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.2838819017148388,2.8028008002286366,3.529278264898223,"['SLIT2', 'RAC1']",0.9999830567881718,0,0,2
151,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.2838819017148388,2.8028008002286366,3.529278264898223,"['ATP4A', 'CHRM1']",0.9999830567881718,0,0,2
152,Sulindac Metabolic Pathway WP2542,0.2838819017148388,2.8028008002286366,3.529278264898223,"['MSRA', 'CYP1B1']",0.9999830567881718,0,0,2
153,Vitamin B6-dependent and responsive disorders WP4228,0.2838819017148388,2.8028008002286366,3.529278264898223,"['PNPO', 'AASS']",0.9999830567881718,0,0,2
154,Focal Adhesion WP306,0.29320857097114766,1.12217403873952,1.376762871365881,"['SHC4', 'LAMA2', 'TXK', 'LAMA4', 'PXN', 'LAMA3', 'TESK2', 'PIK3R3', 'PIK3CD', 'ELK1', 'ACTB', 'THBS4', 'MYL12B', 'ACTG1', 'IGF1R', 'PPP1CC', 'PDGFD', 'RAC3', 'TNR', 'FLNB', 'RAC1', 'HRAS', 'MAPK3', 'PRKCG', 'VAV3', 'PDGFRA', 'JUN', 'MAP2K1', 'CAV3', 'VWF', 'ITGA4', 'LAMB3', 'CAV2', 'EGF', 'BAD', 'FN1', 'VEGFD', 'VAV2', 'ITGA10', 'COL5A2', 'SOS1', 'ITGA9']",0.9999830567881718,0,0,42
155,Differentiation of white and brown adipocyte WP2895,0.29759520478383866,1.5573353674040173,1.8875233081113905,"['CEBPA', 'CEBPB', 'EBF3', 'PPARG', 'ZNF423']",0.9999830567881718,0,0,5
156,NRF2 pathway WP2884,0.3168747000001721,1.1493331321096418,1.3208697819324624,"['SRXN1', 'GSTP1', 'SLC2A1', 'KEAP1', 'SLC2A3', 'TXN', 'SLC7A11', 'FTH1', 'PRDX1', 'SLC39A6', 'SLC39A7', 'SLC39A1', 'SLC39A3', 'GSTM3', 'EGR1', 'HSP90AA1', 'TGFB1', 'SLC6A16', 'GPX3', 'SLC2A12', 'SLC39A11', 'NRG1', 'SLC2A9', 'SLC5A8', 'FTL']",0.9999830567881718,0,0,25
157,Endochondral Ossification with Skeletal Dysplasias WP4808,0.3176025570215567,1.2460749657654215,1.429191287535294,"['ACAN', 'TGFB1', 'THRA', 'STAT1', 'PTCH1', 'ENPP1', 'TIMP3', 'PTH1R', 'CALM1', 'CALM2', 'IGF1R', 'SOX5']",0.9999830567881718,0,0,12
158,Endochondral Ossification WP474,0.3176025570215567,1.2460749657654215,1.429191287535294,"['ACAN', 'TGFB1', 'THRA', 'STAT1', 'PTCH1', 'ENPP1', 'TIMP3', 'PTH1R', 'CALM1', 'CALM2', 'IGF1R', 'SOX5']",0.9999830567881718,0,0,12
159,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.32311205933320436,1.6016994158258098,1.8095296581774114,"['RPH3AL', 'MYRIP', 'SYTL3', 'EXPH5']",0.9999830567881718,0,0,4
160,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.32311205933320436,1.6016994158258098,1.8095296581774114,"['CDKN1A', 'ENPP1', 'ROS1', 'NFKB1']",0.9999830567881718,0,0,4
161,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.32311205933320436,1.6016994158258098,1.8095296581774114,"['ZEB1', 'JAK2', 'NFKB1', 'SOX4']",0.9999830567881718,0,0,4
162,Glycosylation and related congenital defects WP4521,0.32675783631618266,1.3192098482679644,1.4755836331780885,"['DPAGT1', 'GMPPB', 'DPM2', 'DPM3', 'MPI', 'PMM2', 'DOLK', 'MGAT2']",0.9999830567881718,0,0,8
163,Tryptophan metabolism WP465,0.32675783631618266,1.3192098482679644,1.4755836331780885,"['WARS', 'TDO2', 'HAAO', 'ALDH1A1', 'CYP1B1', 'DHCR24', 'CYP2C18', 'ACMSD']",0.9999830567881718,0,0,8
164,Globo Sphingolipid Metabolism WP1424,0.3284507132971296,1.4015736766809728,1.5604679651415654,"['B3GALNT1', 'ST8SIA1', 'ST6GALNAC3', 'FUT1', 'ABO', 'ST6GALNAC5']",0.9999830567881718,0,0,6
165,Immune response to tuberculosis WP4197,0.3284507132971296,1.4015736766809728,1.5604679651415654,"['IFNAR2', 'STAT1', 'TAP1', 'IFIT1', 'JAK2', 'IFIT3']",0.9999830567881718,0,0,6
166,Ovarian infertility WP34,0.3284507132971296,1.4015736766809728,1.5604679651415654,"['EGR1', 'CEBPB', 'CDKN1B', 'SMPD1', 'FSHR', 'BMPR1B']",0.9999830567881718,0,0,6
167,Toll-like Receptor Signaling related to MyD88 WP3858,0.3284507132971296,1.4015736766809728,1.5604679651415654,"['TICAM2', 'IRAK1', 'TRAF3', 'TOLLIP', 'NFKB1', 'RELB']",0.9999830567881718,0,0,6
168,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.33187304989765715,1.2148987003058105,1.340036623224031,"['EIF4A2', 'MAP2K1', 'PRKCD', 'RPS6', 'PIK3R3', 'RPTOR', 'RPS6KA5', 'RPS6KA2', 'PIM2', 'EIF4B', 'MAP2K5', 'MAPK3', 'EIF4G1']",0.9999830567881718,0,0,13
169,Acute viral myocarditis WP4298,0.33674909032554556,1.1805180095144605,1.284896065182582,"['ENDOG', 'TGFB1', 'LAMA2', 'STAT1', 'ACTB', 'SGCD', 'CASP6', 'ABL1', 'RAC3', 'CYCS', 'BAX', 'SOS1', 'SGCG', 'EIF4G2', 'MAPK3', 'EIF4G1']",0.9999830567881718,0,0,16
170,16p11.2 proximal deletion syndrome WP4949,0.3392903467584182,1.1581112803735985,1.2518013920823516,"['PCNA', 'DOC2A', 'IGFBP3', 'SEZ6L2', 'CORO1A', 'NFKB1', 'PPP2CA', 'CCT6A', 'PPP2CB', 'ASPHD1', 'TCP1', 'TMEM219', 'PPARG', 'ALDOA', 'CCT7', 'CDIPT', 'YPEL3', 'CCT4', 'MAPK3']",0.9999830567881718,0,0,19
171,Cardiac Hypertrophic Response WP2795,0.3448187270087729,1.1893874216787896,1.2663841160522515,"['MAP2K1', 'TGFB1', 'MAP3K1', 'EGF', 'NRG1', 'HDAC9', 'TGFBR1', 'NFKB1', 'RAC1', 'PRKD1', 'CALM1', 'CALM2', 'MAP2K5', 'MAPK3']",0.9999830567881718,0,0,14
172,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.35337028494234923,1.2014494533841051,1.2497943448416873,"['MAP2K1', 'JUN', 'CHP1', 'MAP3K8', 'PRKCQ', 'LCP2', 'FOS', 'SOS1', 'CALM1', 'CALM2', 'NFKB1', 'MAPK3']",0.9999830567881718,0,0,12
173,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.35416767614325023,1.681646655231561,1.7455236949642574,"['JAG1', 'TCF7', 'WNT2']",0.9999830567881718,0,0,3
174,"Degradation pathway of sphingolipids, including diseases WP4153",0.35416767614325023,1.681646655231561,1.7455236949642574,"['GM2A', 'NEU1', 'GLA']",0.9999830567881718,0,0,3
175,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.35416767614325023,1.681646655231561,1.7455236949642574,"['IRAK1', 'UBE2N', 'NFKB1']",0.9999830567881718,0,0,3
176,Leptin and adiponectin WP3934,0.35416767614325023,1.681646655231561,1.7455236949642574,"['LEPR', 'ADIPOR1', 'ACACA']",0.9999830567881718,0,0,3
177,Trans-sulfuration pathway WP2333,0.35416767614325023,1.681646655231561,1.7455236949642574,"['AHCY', 'GOT1', 'MAT2B']",0.9999830567881718,0,0,3
178,ERK Pathway in Huntington's Disease WP3853,0.3571838802314611,1.4014588100686498,1.4428082343978872,"['RPS6KA5', 'EGF', 'BDNF', 'ELK1', 'HRAS']",0.9999830567881718,0,0,5
179,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.3571838802314611,1.4014588100686498,1.4428082343978872,"['TJP1', 'JUN', 'PXN', 'PRKCQ', 'MAPK3']",0.9999830567881718,0,0,5
180,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.3571838802314611,1.4014588100686498,1.4428082343978872,"['TGFB1', 'SUV39H1', 'CDC37', 'FN1', 'NRF1']",0.9999830567881718,0,0,5
181,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.357871938616592,1.132277851458886,1.1635061537909148,"['PRKCG', 'SHC4', 'PDGFRA', 'MAP2K1', 'BAD', 'EGF', 'RPS6', 'GAB1', 'PIK3CD', 'RRAS2', 'PIK3R3', 'NRG1', 'NRG2', 'IGF1R', 'BCL2L11', 'PDGFD', 'BAX', 'JAK2', 'SOS1', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,21
182,Circadian rhythm related genes WP3594,0.3601352225914753,1.0846957138183009,1.10777337414477,"['MAGEL2', 'NLGN1', 'AHCY', 'CHRM1', 'SUV39H1', 'CIPC', 'BHLHE41', 'OPRL1', 'RORA', 'RELB', 'PPP1CC', 'DBP', 'UBC', 'RPS27A', 'SKP1', 'PRKCG', 'CHRNB2', 'KLF10', 'EGR1', 'JUN', 'EGR3', 'JUND', 'KCND2', 'KCNH7', 'USP2', 'NR1D2', 'CARTPT', 'HCRTR2', 'NR2F6', 'HS3ST2', 'PER2', 'STAR', 'ADORA2A', 'BHLHE40', 'PPARG', 'GHRL', 'ATF5', 'PPARA', 'UBA52', 'ATF4', 'EZH2']",0.9999830567881718,0,0,41
183,Parkinson's disease pathway WP2371,0.3624529862561304,1.218786195558766,1.2368979753558402,"['PRKN', 'PINK1', 'UBB', 'CCNE2', 'CASP6', 'SYT11', 'HTRA2', 'CYCS', 'UBE2L6', 'PARK7']",0.9999830567881718,0,0,10
184,IL-4 signaling pathway WP395,0.3663414361329616,1.1755881917727138,1.180513312434856,"['CEBPA', 'CEBPB', 'STAT1', 'BAD', 'PIK3CD', 'FOS', 'GAB2', 'ELK1', 'NFKB1', 'HRH1', 'JAK2', 'SOS1', 'MAPK3']",0.9999830567881718,0,0,13
185,Endothelin Pathways WP2197,0.3720875787062629,1.245793173648885,1.2316235542180076,"['ADCY10', 'MAP2K1', 'CALCRL', 'RIIAD1', 'ATP2A2', 'ADRB1', 'CALM1', 'CALM2']",0.9999830567881718,0,0,8
186,IL-7 signaling pathway WP205,0.38215827477474434,1.2936282601518654,1.2443674449127757,"['MAP2K1', 'CDKN1B', 'STAT1', 'BAD', 'IL7', 'MAPK3']",0.9999830567881718,0,0,6
187,Striated Muscle Contraction Pathway WP383,0.38215827477474434,1.2936282601518654,1.2443674449127757,"['ACTA2', 'MYOM1', 'MYBPC1', 'ACTC1', 'TCAP', 'ACTG1']",0.9999830567881718,0,0,6
188,CAMKK2  Pathway WP4874,0.38857238108466574,1.201276386843397,1.1355375185322456,"['RPTOR', 'FIS1', 'MAP1LC3A', 'WFS1', 'RAC1', 'CAMK1', 'CALM1', 'CALM2', 'MAPK3']",0.9999830567881718,0,0,9
189,Neural Crest Cell Migration during Development WP4564,0.38857238108466574,1.201276386843397,1.1355375185322456,"['ARF1', 'JUN', 'BDNF', 'CDH11', 'PIK3R3', 'PIK3CD', 'RAC1', 'FOS', 'EPHB3']",0.9999830567881718,0,0,9
190,3q29 copy number variation syndrome WP4906,0.3888664522235127,1.1364376424617388,1.0733872919924508,"['JUN', 'TGFB1', 'NCBP2', 'DYNLT3', 'PXN', 'PIK3R3', 'MAD2L1BP', 'FBXO45', 'DYNLL1', 'DYNLL2', 'PIGX', 'TF', 'UBE2N', 'NF2', 'DYNLRB1']",0.9999830567881718,0,0,15
191,PPAR signaling pathway WP3942,0.38973378698575173,1.1599015625463278,1.092965232908538,"['CYP27A1', 'CPT2', 'FABP5', 'FABP6', 'FABP7', 'APOA1', 'ACSL5', 'LPL', 'PPARG', 'CD36', 'PPARA', 'CPT1B']",0.9999830567881718,0,0,12
192,Cancer immunotherapy by PD-1 blockade WP4585,0.3918636233745805,1.4013440091507006,1.312837082401752,"['JUN', 'NFATC3', 'PDCD1LG2', 'NFKB1']",0.9999830567881718,0,0,4
193,Ganglio Sphingolipid Metabolism WP1423,0.3918636233745805,1.4013440091507006,1.312837082401752,"['ST8SIA1', 'B3GALT1', 'B3GALT4', 'FUT1']",0.9999830567881718,0,0,4
194,miRNAs involved in DNA damage response WP1545,0.3918636233745805,1.4013440091507006,1.312837082401752,"['CDKN1A', 'CDKN1B', 'H2AFX', 'ABL1']",0.9999830567881718,0,0,4
195,Overview of nanoparticle effects WP3287,0.3918636233745805,1.4013440091507006,1.312837082401752,"['LAMA3', 'FN1', 'PIK3CD', 'BAX']",0.9999830567881718,0,0,4
196,Serotonin and anxiety WP3947,0.3918636233745805,1.4013440091507006,1.312837082401752,"['GABRA1', 'ARC', 'TRPV1', 'FOS']",0.9999830567881718,0,0,4
197,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.3918636233745805,1.4013440091507006,1.312837082401752,"['CDH6', 'TGFB1', 'FN1', 'MAPK3']",0.9999830567881718,0,0,4
198,Cytokines and Inflammatory Response WP530,0.394671025643176,1.8683433361912927,1.737003858314884,"['TGFB1', 'IL7']",0.9999830567881718,0,0,2
199,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.394671025643176,1.8683433361912927,1.737003858314884,"['CDKN1A', 'ABCB1']",0.9999830567881718,0,0,2
200,LTF danger signal response pathway WP4478,0.394671025643176,1.8683433361912927,1.737003858314884,"['IRAK1', 'NFKB1']",0.9999830567881718,0,0,2
201,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.394671025643176,1.8683433361912927,1.737003858314884,"['EGF', 'FN1']",0.9999830567881718,0,0,2
202,Mitochondrial fatty acid synthesis pathway WP4317,0.394671025643176,1.8683433361912927,1.737003858314884,"['MCAT', 'ACACA']",0.9999830567881718,0,0,2
203,PTF1A related regulatory pathway WP4147,0.394671025643176,1.8683433361912927,1.737003858314884,"['KAT2B', 'FGF10']",0.9999830567881718,0,0,2
204,Toll-like Receptor Signaling Pathway WP75,0.39877712177350255,1.1212625538020087,1.0308356555678142,"['IFNAR2', 'MAP2K1', 'JUN', 'TICAM2', 'STAT1', 'PIK3R3', 'PIK3CD', 'FOS', 'NFKB1', 'IRAK1', 'TRAF3', 'TOLLIP', 'MAP3K8', 'FADD', 'RAC1', 'MAPK3']",0.9999830567881718,0,0,16
205,Pre-implantation embryo WP3527,0.4017436005549056,1.226227103606182,1.1182470205228054,"['EGR1', 'BATF3', 'ARGFX', 'DDIT3', 'HMGA1', 'ATP1A1', 'HNRNPAB']",0.9999830567881718,0,0,7
206,One-carbon metabolism WP241,0.41707407657411,1.2739234449760766,1.1140351367576606,"['AHCY', 'CHDH', 'DNMT3A', 'GLRX', 'MAT2B']",0.9999830567881718,0,0,5
207,Pregnane X receptor pathway WP2876,0.41707407657411,1.2739234449760766,1.1140351367576606,"['HSP90AA1', 'PSMC5', 'ABCB1', 'CYP3A5', 'CYP3A7']",0.9999830567881718,0,0,5
208,Urea cycle and metabolism of amino groups WP497,0.41707407657411,1.2739234449760766,1.1140351367576606,"['CPS1', 'ODC1', 'PYCR3', 'CKB', 'SRM']",0.9999830567881718,0,0,5
209,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.41780704951205283,1.1801045700423403,1.0299192193337727,"['NDUFA13', 'HSP90AA1', 'COPS6', 'IL18', 'NLRC4', 'RAC1', 'NLRP1', 'AAMP']",0.9999830567881718,0,0,8
210,Prostaglandin Synthesis and Regulation WP98,0.41780704951205283,1.1801045700423403,1.0299192193337727,"['HSD11B1', 'HSD11B2', 'ANXA1', 'S100A6', 'MITF', 'PPARG', 'PTGDR', 'PTGES']",0.9999830567881718,0,0,8
211,Androgen receptor signaling pathway WP138,0.41925308299144115,1.0818999208282276,0.9404745308706148,"['CDKN1A', 'JUN', 'LIMK2', 'NCOA4', 'DSTN', 'RNF6', 'PARK7', 'ETV5', 'RHOB', 'KAT2B', 'AR', 'SUMO1', 'KAT5', 'PRDX1', 'BAG1', 'RACK1', 'STUB1', 'RAC1', 'CALR', 'FKBP4', 'RAN', 'RAD9A']",0.9999830567881718,0,0,22
212,Osteoblast differentiation WP4787,0.42624071908902617,1.0745016292888634,0.9162823646868428,"['PRKCG', 'FZD1', 'PRKCH', 'JAG1', 'STAT1', 'NOTCH4', 'PTCH1', 'PRKCD', 'WNT8A', 'PIK3R3', 'PIK3CD', 'WNT7A', 'WNT9A', 'FGF1', 'DLL3', 'HEY1', 'PRKCQ', 'PPARG', 'PRKD1', 'BMPR1B', 'WNT2', 'FGF10', 'MAPK3']",0.9999830567881718,0,0,23
213,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.42636311699802293,1.1211235310977357,0.9557173471963989,"['KAT2B', 'CEBPA', 'CDKN1A', 'CEBPB', 'TGFB1', 'ICMT', 'CTSK', 'TCF7', 'LMNA', 'PPARG', 'EMD', 'ACTB']",0.9999830567881718,0,0,12
214,IL-2 signaling pathway WP49,0.43140802610283413,1.146555763823805,0.9639105088888414,"['MAP2K1', 'JUN', 'STAT1', 'RPS6', 'FOS', 'GAB2', 'SOS1', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,9
215,Pathways Regulating Hippo Signaling WP4540,0.4320625900466076,1.0780500740282413,0.9046832539453425,"['PRKCG', 'PDGFRA', 'PRKCH', 'FLT3', 'PRKCD', 'TCF7', 'IGF1R', 'CDH7', 'CDH6', 'CDH4', 'PRKD3', 'PRKAR1A', 'CDH20', 'CDH11', 'CDH12', 'PRKCQ', 'NF2', 'RAC1', 'PLCB2', 'CDH18']",0.9999830567881718,0,0,20
216,Biotin Metabolism (including IEMs) WP5031,0.4358293283365467,1.4012292738707832,1.1637273030104358,"['PCCA', 'ACACB', 'ACACA']",0.9999830567881718,0,0,3
217,Cancer immunotherapy by CTLA4 blockade WP4582,0.4358293283365467,1.4012292738707832,1.1637273030104358,"['PPP2CA', 'PIK3CD', 'PIK3R3']",0.9999830567881718,0,0,3
218,Estrogen Receptor Pathway WP2881,0.4358293283365467,1.4012292738707832,1.1637273030104358,"['JUN', 'CYP1B1', 'PPARA']",0.9999830567881718,0,0,3
219,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.4358293283365467,1.4012292738707832,1.1637273030104358,"['MAP2K1', 'PRKCQ', 'MAFK']",0.9999830567881718,0,0,3
220,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.4358293283365467,1.4012292738707832,1.1637273030104358,"['JUN', 'PRKCQ', 'MAPK3']",0.9999830567881718,0,0,3
221,Serotonin and anxiety-related events WP3944,0.4358293283365467,1.4012292738707832,1.1637273030104358,"['NLGN1', 'ARC', 'FOS']",0.9999830567881718,0,0,3
222,1q21.1 copy number variation syndrome WP4905,0.43588026907673383,1.2011036174126304,0.9973816529753318,"['TJP1', 'PYGO1', 'PYGO2', 'ACP6', 'FMO5', 'TJP2']",0.9999830567881718,0,0,6
223,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.43588026907673383,1.2011036174126304,0.9973816529753318,"['GOT1', 'MDH2', 'SCO2', 'GOT2', 'HMGA1', 'SLC2A1']",0.9999830567881718,0,0,6
224,SARS-CoV-2 mitochondrial interactions WP5038,0.43588026907673383,1.2011036174126304,0.9973816529753318,"['IFIH1', 'NDUFB9', 'TRAF3', 'PHB', 'PHB2', 'NFKB1']",0.9999830567881718,0,0,6
225,Urea cycle and associated pathways WP4595,0.43588026907673383,1.2011036174126304,0.9973816529753318,"['LDHB', 'GOT1', 'CPS1', 'MDH2', 'GOT2', 'GPT']",0.9999830567881718,0,0,6
226,IL-6 signaling pathway WP364,0.4432000779719038,1.1210541392151245,0.9122398326200025,"['MAP2K1', 'STAT1', 'BAD', 'PRKCD', 'GAB1', 'RAC1', 'JAK2', 'SOS1', 'MAPK3', 'NR2F6']",0.9999830567881718,0,0,10
227,Neovascularisation processes WP4331,0.45085294166162093,1.153978248425873,0.9192753026570896,"['TGFB1', 'JAG1', 'NOTCH4', 'NFKB1', 'TGFBR1', 'RELB', 'MAPK3']",0.9999830567881718,0,0,7
228,Arylamine metabolism WP694,0.4568972121846776,2.8022857142857145,2.1950215224121346,['SULT1A2'],0.9999830567881718,0,0,1
229,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.4568972121846776,2.8022857142857145,2.1950215224121346,['TGFB1'],0.9999830567881718,0,0,1
230,COVID-19 adverse outcome pathway WP4891,0.4568972121846776,2.8022857142857145,2.1950215224121346,['IL7'],0.9999830567881718,0,0,1
231,SCFA and skeletal muscle substrate metabolism WP4030,0.4568972121846776,2.8022857142857145,2.1950215224121346,['PYY'],0.9999830567881718,0,0,1
232,Thyroxine (Thyroid Hormone) Production WP1981,0.4568972121846776,2.8022857142857145,2.1950215224121346,['TSHR'],0.9999830567881718,0,0,1
233,BMP Signaling Pathway in Eyelid Development WP3927,0.45942607180359873,1.2455120261811712,0.9687309042160634,"['JUN', 'MAP3K1', 'MAPK3', 'FGF10']",0.9999830567881718,0,0,4
234,Nicotine Activity on Dopaminergic Neurons WP1602,0.45942607180359873,1.2455120261811712,0.9687309042160634,"['CHRNB2', 'CDK5', 'PPP1R1B', 'SLC18A2']",0.9999830567881718,0,0,4
235,Phytochemical activity on NRF2 transcriptional activation WP3,0.45942607180359873,1.2455120261811712,0.9687309042160634,"['AIMP2', 'CEBPB', 'KEAP1', 'SLC7A11']",0.9999830567881718,0,0,4
236,Breast cancer pathway WP4262,0.4620161881148629,1.042032228524164,0.8046107594027236,"['SHC4', 'CDKN1A', 'NOTCH4', 'TCF7', 'PIK3R3', 'PIK3CD', 'FGF1', 'IGF1R', 'DLL3', 'FRAT1', 'FRAT2', 'HEY1', 'WNT2', 'HRAS', 'SKP1', 'MAPK3', 'FZD1', 'MAP2K1', 'JUN', 'GADD45B', 'GADD45A', 'EGF', 'WNT7A', 'FOS', 'FGF17', 'CSNK2B', 'BAX', 'SOS1', 'FGF10']",0.9999830567881718,0,0,29
237,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.46946890661739515,1.0325568682236463,0.7807711894999235,"['SHC4', 'RAB3A', 'ELK1', 'ACACB', 'PPP2CA', 'GRIP1', 'RPS6KA5', 'BCL2L11', 'CFL1', 'RACK1', 'RAC1', 'JAK2', 'HRAS', 'MAP2K5', 'MAPK3', 'NSF', 'VAV3', 'EGR1', 'MAP2K1', 'JUN', 'EGR2', 'MAP3K1', 'BDNF', 'STAT1', 'BAD', 'RPS6', 'PRKCD', 'FOS', 'EEF2', 'NFKB1', 'VAV2', 'MARCKS', 'CDK5', 'CAMK1', 'CDK5R1']",0.9999830567881718,0,0,35
238,Disruption of postsynaptic signaling by CNV WP4875,0.473960359935533,1.0965934558493948,0.8187513150990988,"['TJP1', 'RYR2', 'NLGN1', 'ARC', 'DLG2', 'NRXN3', 'YWHAG', 'MAPK3', 'SHANK1']",0.9999830567881718,0,0,9
239,Signaling of Hepatocyte Growth Factor Receptor WP313,0.473960359935533,1.0965934558493948,0.8187513150990988,"['MAP2K1', 'JUN', 'PXN', 'GAB1', 'FOS', 'SOS1', 'ELK1', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,9
240,Leptin signaling pathway WP2034,0.47561684360724255,1.0509259259259258,0.7809879293592632,"['GSK3A', 'MAP2K1', 'STAT1', 'BAD', 'PDE3B', 'RPS6', 'ELK1', 'ACACB', 'ACACA', 'NFKB1', 'CFL2', 'LEPR', 'BAX', 'RAC1', 'JAK2', 'SOS1', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,18
241,Purinergic signaling WP4900,0.4759281096798851,1.1676439740655988,0.866962183419727,"['P2RY12', 'GNAZ', 'ADORA2A', 'LPAR6', 'P2RY14']",0.9999830567881718,0,0,5
242,Triacylglyceride synthesis WP325,0.4759281096798851,1.1676439740655988,0.866962183419727,"['DGAT2', 'MOGAT1', 'LPL', 'AGPAT1', 'AGPAT2']",0.9999830567881718,0,0,5
243,Vitamin B12 metabolism WP1533,0.4759281096798851,1.1676439740655988,0.866962183419727,"['CUBN', 'APOA1', 'SOD2', 'NFKB1', 'SOD1']",0.9999830567881718,0,0,5
244,DNA damage response (only ATM dependent) WP710,0.4782956563151836,1.0396269639577806,0.7667521343795743,"['JUN', 'CDKN1A', 'TGFB1', 'CDKN1B', 'MAP3K1', 'CDKN2A', 'BAD', 'TCF7', 'PIK3R3', 'PIK3CD', 'WNT7A', 'SOD2', 'NFKB1', 'FRAT1', 'BCL2L11', 'CCNG2', 'ABL1', 'RAC3', 'BAX', 'RAC1', 'SOS1', 'WNT2', 'HRAS']",0.9999830567881718,0,0,23
245,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.4791323386015526,1.0603709531154326,0.7801980843520424,"['FZD1', 'JUN', 'CTBP2', 'SERPINF1', 'TCF7', 'WNT7A', 'CXXC4', 'FRAT1', 'FRAT2', 'SFRP2', 'CSNK2B', 'ROR1', 'WNT2', 'EZH2']",0.9999830567881718,0,0,14
246,Cardiac Progenitor Differentiation WP2406,0.48867253642820674,1.1209155937052933,0.8026458167801578,"['MESP1', 'PDGFRA', 'TGFB1', 'ACTC1', 'NRG1', 'THY1']",0.9999830567881718,0,0,6
247,Differentiation Pathway WP2848,0.48867253642820674,1.1209155937052933,0.8026458167801578,"['TF', 'TGFB1', 'EGF', 'FGF1', 'WNT2', 'FGF10']",0.9999830567881718,0,0,6
248,Type II interferon signaling (IFNG) WP619,0.48867253642820674,1.1209155937052933,0.8026458167801578,"['STAT1', 'PRKCD', 'TAP1', 'ISG15', 'JAK2', 'IFIT2']",0.9999830567881718,0,0,6
249,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.49290356765760535,1.0427146241366654,0.7376598346768,"['FZD1', 'JUN', 'CTBP2', 'SERPINF1', 'TCF7', 'WNT7A', 'CXXC4', 'CDK8', 'FRAT1', 'FRAT2', 'SFRP2', 'HNRNPK', 'CSNK2B', 'ROR1', 'WNT2', 'EZH2']",0.9999830567881718,0,0,16
250,TNF-alpha signaling pathway WP231,0.49362723029447575,1.0324258923169993,0.7288664988833263,"['HSP90AA1', 'JUN', 'MAP3K1', 'BAD', 'TRADD', 'KSR2', 'TXN', 'NFKB1', 'PPP2CA', 'PSMD2', 'RFK', 'CDC37', 'BAX', 'MAP3K8', 'RAC1', 'FADD', 'SOS1', 'NFKBIE', 'HRAS', 'SKP1', 'MAPK3']",0.9999830567881718,0,0,21
251,Drug Induction of Bile Acid Pathway WP2289,0.4967377408684186,1.4011146041726208,0.9803501879636478,"['ABCB1', 'SLC10A1']",0.9999830567881718,0,0,2
252,Insulin signaling in adipocytes (diabetic condition) WP3635,0.4967377408684186,1.4011146041726208,0.9803501879636478,"['TBC1D4', 'RPS6']",0.9999830567881718,0,0,2
253,Insulin signaling in adipocytes (normal condition) WP3634,0.4967377408684186,1.4011146041726208,0.9803501879636478,"['TBC1D4', 'RPS6']",0.9999830567881718,0,0,2
254,LDLRAD4 and what we know about it WP4904,0.4967377408684186,1.4011146041726208,0.9803501879636478,"['PMEPA1', 'TGFBR1']",0.9999830567881718,0,0,2
255,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.4967377408684186,1.4011146041726208,0.9803501879636478,"['CHI3L1', 'BAX']",0.9999830567881718,0,0,2
256,Nephrogenesis WP5052,0.4967377408684186,1.4011146041726208,0.9803501879636478,"['JAG1', 'GREB1L']",0.9999830567881718,0,0,2
257,Peroxiredoxin 2 induced ovarian failure WP4873,0.4967377408684186,1.4011146041726208,0.9803501879636478,"['STAR', 'BAX']",0.9999830567881718,0,0,2
258,Glucocorticoid Receptor Pathway WP2880,0.4991643151240512,1.0508383490971624,0.7301434477155642,"['TGFBR3', 'FGD4', 'HSP90AA1', 'MGAM', 'JUN', 'GADD45B', 'TSC22D3', 'PLK2', 'ENC1', 'AMIGO2', 'BHLHE40', 'SPRY1']",0.9999830567881718,0,0,12
259,Phosphodiesterases in neuronal function WP4222,0.4991643151240512,1.0508383490971624,0.7301434477155642,"['ADCY10', 'ADCY9', 'PDE10A', 'ADORA2A', 'PDE4D', 'PDE1A', 'PDE3B', 'PPP1R1B', 'PDE3A', 'PDE6C', 'PDE5A', 'PDE7B']",0.9999830567881718,0,0,12
260,RANKL/RANK signaling pathway WP2018,0.4991643151240512,1.0508383490971624,0.7301434477155642,"['MAP2K1', 'JUN', 'TRAF3', 'STAT1', 'CTSK', 'MITF', 'RAC1', 'FOS', 'GAB2', 'NFKB1', 'RELB', 'MAPK3']",0.9999830567881718,0,0,12
261,Genotoxicity pathway WP4286,0.506044404087347,1.0408093053735255,0.7089273356326586,"['PLK3', 'BTG2', 'CDKN1A', 'GADD45A', 'EI24', 'PCDH8', 'TRIAP1', 'ACTA2', 'RPS27', 'BLOC1S2', 'B3GNT2', 'TRIM22', 'PHLDA3']",0.9999830567881718,0,0,13
262,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.506044404087347,1.0408093053735255,0.7089273356326586,"['PRKCG', 'IFI27L2', 'JUN', 'PRKCH', 'STAT1', 'PRKCD', 'ISG15', 'NFKB1', 'RELB', 'PRKCQ', 'HRAS', 'PLCB2', 'MAPK3']",0.9999830567881718,0,0,13
263,miRNA regulation of prostate cancer signaling pathways WP3981,0.5080004649556583,1.0674955352882636,0.7229858141479422,"['AR', 'CDKN1A', 'MAP2K1', 'CDKN1B', 'BAD', 'TCF7', 'SOS1', 'NFKB1']",0.9999830567881718,0,0,8
264,Alanine and aspartate metabolism WP106,0.5132108598751681,1.2009311443273707,0.8011033194767367,"['GOT1', 'GOT2', 'GPT']",0.9999830567881718,0,0,3
265,Hedgehog Signaling Pathway Netpath WP47,0.5132108598751681,1.2009311443273707,0.8011033194767367,"['PTCH1', 'SUFU', 'SAP18']",0.9999830567881718,0,0,3
266,Nanoparticle triggered regulated necrosis WP2513,0.5132108598751681,1.2009311443273707,0.8011033194767367,"['TRADD', 'FADD', 'FTL']",0.9999830567881718,0,0,3
267,Osteopontin Signaling WP1434,0.5132108598751681,1.2009311443273707,0.8011033194767367,"['MAP2K1', 'NFKB1', 'MAPK3']",0.9999830567881718,0,0,3
268,Neural Crest Cell Migration in Cancer WP4565,0.5157756059131813,1.0507946735395188,0.6957137945863096,"['ARF1', 'JUN', 'BDNF', 'CDH11', 'PIK3R3', 'PIK3CD', 'RAC1', 'FOS', 'EPHB3']",0.9999830567881718,0,0,9
269,Pancreatic adenocarcinoma pathway WP4263,0.5205557905518511,1.0145214030915577,0.6623386274444092,"['CDKN1A', 'MAP2K1', 'TGFB1', 'GADD45B', 'CDKN2A', 'STAT1', 'BAD', 'EGF', 'GADD45A', 'PRKCD', 'PEBP1', 'PIK3CD', 'PIK3R3', 'TGFBR1', 'DUSP6', 'NFKB1', 'RAC3', 'BAX', 'RAC1', 'ARHGEF6', 'MAPK3']",0.9999830567881718,0,0,21
270,Regulation of Actin Cytoskeleton WP51,0.5206253725595771,1.0074463709063584,0.6575849795630738,"['CHRM2', 'CHRM1', 'CHRM5', 'PXN', 'PIK3R3', 'BRK1', 'PIK3CD', 'FGF1', 'ACTB', 'ACTG1', 'CFL2', 'TMSB4X', 'CFL1', 'RAC3', 'PIP5K1B', 'PIP4K2C', 'RAC1', 'MAPK3', 'PDGFRA', 'MAP2K1', 'GSN', 'EGF', 'FN1', 'RRAS2', 'ARPC5', 'SSH2', 'FGF17', 'FGF14', 'SOS1', 'FGF12', 'FGF10', 'ARHGEF6']",0.9999830567881718,0,0,32
271,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.5241583837317741,1.1208464398055475,0.7240235144842758,"['ALOX12', 'TRPV1', 'PPARA', 'LTB4R']",0.9999830567881718,0,0,4
272,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.5241583837317741,1.1208464398055475,0.7240235144842758,"['EGLN2', 'NFKB1', 'BCL2L2', 'RELB']",0.9999830567881718,0,0,4
273,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.5241583837317741,1.1208464398055475,0.7240235144842758,"['GSK3A', 'BAX', 'BCL2L14', 'BCL2L2']",0.9999830567881718,0,0,4
274,SARS coronavirus and innate immunity WP4912,0.5241583837317741,1.1208464398055475,0.7240235144842758,"['IFIH1', 'IFNAR2', 'STAT1', 'TRAF3']",0.9999830567881718,0,0,4
275,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.528970768044323,1.0134719202677285,0.645401324203674,"['CDKN1A', 'MAP2K1', 'JUN', 'TGFB1', 'GADD45B', 'DCC', 'BAD', 'GADD45A', 'TCF7', 'FOS', 'TGFBR1', 'BCL2L11', 'RAC3', 'CYCS', 'BAX', 'RAC1', 'MAPK3']",0.9999830567881718,0,0,17
276,Apoptosis Modulation by HSP70 WP384,0.5326501546977117,1.0777151909875022,0.6788424963788929,"['MAP3K1', 'CASP6', 'CYCS', 'FADD', 'NFKB1']",0.9999830567881718,0,0,5
277,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.5326501546977117,1.0777151909875022,0.6788424963788929,"['JUN', 'SRXN1', 'GSTP1', 'KEAP1', 'FOS']",0.9999830567881718,0,0,5
278,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.5326501546977117,1.0777151909875022,0.6788424963788929,"['EGR1', 'MAP2K1', 'RPS6KA5', 'ELK1', 'MAPK3']",0.9999830567881718,0,0,5
279,Alzheimer's disease WP2059,0.5338622151791079,1.0086821705426356,0.6330665794723433,"['PSENEN', 'ATP5MD', 'BAD', 'ATP2A2', 'ITPR2', 'LPL', 'CACNA1C', 'CDK5', 'CHP1', 'CYCS', 'CALM3', 'FADD', 'CALM1', 'PLCB2', 'GAPDH', 'CALM2', 'MAPK3', 'CDK5R1']",0.9999830567881718,0,0,18
280,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.5347606821154021,1.0188905390969019,0.6377602229497688,"['VAV3', 'BEX3', 'CDKN1A', 'CDKN1B', 'JUND', 'HSPA5', 'SERBP1', 'ABL1', 'NRG1', 'RNF7', 'YBX3', 'NFKB1']",0.9999830567881718,0,0,12
281,7-oxo-C and 7beta-HC pathways WP5064,0.5397391904944273,1.0507510729613734,0.6479658620852611,"['HSD11B1', 'CYP27A1', 'HSD11B2', 'DBP', 'ACOT11', 'ACOT4']",0.9999830567881718,0,0,6
282,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.5459106206260428,1.0322959660169313,0.6248487638428983,"['RPTOR', 'CDKN1B', 'BAD', 'TFEB', 'PIK3R3', 'FOXO4', 'HRAS']",0.9999830567881718,0,0,7
283,The influence of laminopathies on Wnt signaling WP4844,0.5459106206260428,1.0322959660169313,0.6248487638428983,"['CEBPA', 'CEBPB', 'ICMT', 'TCF7', 'LMNA', 'PPARG', 'EMD']",0.9999830567881718,0,0,7
284,BDNF-TrkB Signaling WP3676,0.5514288361275751,1.0188689066444578,0.6064740604453337,"['MAP2K1', 'ARC', 'TRPC6', 'BDNF', 'GAB1', 'GAB2', 'SOS1', 'HRAS']",0.9999830567881718,0,0,8
285,MAPK Cascade WP422,0.5514288361275751,1.0188689066444578,0.6064740604453337,"['MAP2K1', 'JUN', 'MAP3K1', 'SOS1', 'ELK1', 'HRAS', 'LAMTOR3', 'MAPK3']",0.9999830567881718,0,0,8
286,Apoptosis WP254,0.5541431541584589,0.9961677028534991,0.5880698961067475,"['JUN', 'MAP3K1', 'CRADD', 'CDKN2A', 'BAD', 'TRADD', 'NFKB1', 'IGF1R', 'BCL2L11', 'CASP6', 'TRAF3', 'CYCS', 'BAX', 'FADD', 'NFKBIE', 'BCL2L2']",0.9999830567881718,0,0,16
287,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5541431541584589,0.9961677028534991,0.5880698961067475,"['EGR1', 'MAP2K1', 'JUN', 'CDKN1B', 'STAT1', 'PDE4D', 'KCNIP3', 'RPS6', 'FOS', 'TSHR', 'IGF1R', 'MYL12B', 'APEX1', 'JAK2', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,16
288,Ciliary landscape WP4352,0.563606141168987,0.9852353823088456,0.5649335767735902,"['DOCK5', 'ZMYND19', 'MYL6B', 'RPGR', 'PSMD8', 'PSMD7', 'ARHGDIA', 'NEFL', 'BBS9', 'NEFM', 'TMED1', 'RAC1', 'NINL', 'NUDC', 'EXOC8', 'DYNLT3', 'DYNLL1', 'DYNLL2', 'MYL6', 'TBC1D4', 'ERF', 'MCM3', 'CD2BP2', 'ANKS6', 'MCM4', 'MCM6', 'ARL8B', 'CTBP2', 'SSNA1', 'VPS4A', 'HTRA2', 'COPS7A', 'AGPAT2', 'PGRMC2', 'EXOSC4', 'SNRPB2', 'DCAF11', 'NDUFA5', 'RHBDD2', 'H3F3A', 'COX6C', 'LSM4', 'NFKB1', 'COPS6', 'RAB14', 'GID8', 'DYNLRB1', 'CALM1', 'COPS8', 'CALM2', 'GLA']",0.9999830567881718,0,0,51
289,GPR40 Pathway WP3958,0.5844978611505748,1.0507075471698113,0.5642322195816416,"['PLCL1', 'PLCH1', 'PLCB2']",0.9999830567881718,0,0,3
290,Leptin Insulin Overlap WP3935,0.5844978611505748,1.0507075471698113,0.5642322195816416,"['LEPR', 'PIK3R3', 'JAK2']",0.9999830567881718,0,0,3
291,"NAD metabolism, sirtuins and aging WP3630",0.5844978611505748,1.0507075471698113,0.5642322195816416,"['PPARG', 'ROS1', 'NFKB1']",0.9999830567881718,0,0,3
292,RAS and bradykinin pathways in COVID-19 WP4969,0.5844978611505748,1.0507075471698113,0.5642322195816416,"['F12', 'KLKB1', 'NFKB1']",0.9999830567881718,0,0,3
293,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5844978611505748,1.0507075471698113,0.5642322195816416,"['STAG1', 'ANAPC11', 'MAD2L1']",0.9999830567881718,0,0,3
294,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.584876344749201,1.0188473236800375,0.5464636836900247,"['ABCB1', 'RARB', 'PPARG', 'PPARA']",0.9999830567881718,0,0,4
295,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.5863972200174102,1.0006333769205622,0.5340959390980201,"['FZD1', 'PDGFRA', 'PTCH1', 'FGF1', 'NFKB1']",0.9999830567881718,0,0,5
296,Aspirin and miRNAs WP4707,0.5870050911308471,1.1207773649614174,0.5970625196329649,"['PPARA', 'NFKB1']",0.9999830567881718,0,0,2
297,Ketogenesis and Ketolysis WP4742,0.5870050911308471,1.1207773649614174,0.5970625196329649,"['CPT2', 'SLC2A1']",0.9999830567881718,0,0,2
298,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.5870050911308471,1.1207773649614174,0.5970625196329649,"['TGFB1', 'NRG3']",0.9999830567881718,0,0,2
299,Osteoblast Signaling WP322,0.5870050911308471,1.1207773649614174,0.5970625196329649,"['PDGFRA', 'PTH1R']",0.9999830567881718,0,0,2
300,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.5870050911308471,1.1207773649614174,0.5970625196329649,"['ELK1', 'MEF2D']",0.9999830567881718,0,0,2
301,Sulfation Biotransformation Reaction WP692,0.5870050911308471,1.1207773649614174,0.5970625196329649,"['SULT4A1', 'SULT1A2']",0.9999830567881718,0,0,2
302,Non-small cell lung cancer WP4255,0.5870155081533881,0.9719065582605029,0.5177385502449726,"['PRKCG', 'CDKN1A', 'MAP2K1', 'GADD45B', 'CDKN2A', 'BAD', 'EGF', 'GADD45A', 'PIK3CD', 'PIK3R3', 'FHIT', 'RARB', 'CYCS', 'BAX', 'SOS1', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,17
303,Signal transduction through IL1R WP4496,0.5884434856569171,0.9888412017167382,0.524357163131141,"['JUN', 'TGFB1', 'MAP3K1', 'IRAK1', 'TOLLIP', 'NFKB1']",0.9999830567881718,0,0,6
304,Retinoblastoma gene in cancer WP2446,0.5901089779435056,0.9696879348042139,0.5114600110580125,"['BARD1', 'CDKN1A', 'CDKN1B', 'PCNA', 'H2AFZ', 'SUV39H1', 'RPA2', 'DCK', 'CCNE2', 'TFDP2', 'RPA3', 'POLE2', 'STMN1', 'MCM3', 'ABL1', 'MCM4', 'MCM6', 'SKP2']",0.9999830567881718,0,0,18
305,GABA receptor Signaling WP4159,0.5907468427756484,0.9805809959931311,0.5161461707449688,"['GABRA1', 'GABRB1', 'GABBR1', 'AP2S1', 'GABRD', 'GABRG3', 'AP2M1']",0.9999830567881718,0,0,7
306,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5907468427756484,0.9805809959931311,0.5161461707449688,"['IFIH1', 'IFNAR2', 'JUN', 'STAT1', 'TRAF3', 'FOS', 'NFKB1']",0.9999830567881718,0,0,7
307,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.5918713716482292,0.9696094061379036,0.5085271137886173,"['SPARC', 'NOTCH4', 'EIF5A2', 'WNT8A', 'PIK3R3', 'PIK3CD', 'DLL3', 'CLDN20', 'WNT2', 'HRAS', 'MEF2D', 'MAPK3', 'FZD1', 'MAP2K1', 'TGFB1', 'JAG1', 'FN1', 'WNT7A', 'WNT9A', 'TGFBR1', 'TJP1', 'ZEB1', 'FMNL2', 'PKP2', 'STRAP', 'SOS1', 'EZH2']",0.9999830567881718,0,0,27
308,Target Of Rapamycin (TOR) Signaling WP1471,0.5931751794293986,0.9744706804914176,0.5089324283094498,"['PRR5', 'RPTOR', 'FKBP1A', 'IDI1', 'RRAGA', 'RRAGC', 'DDIT4', 'RAC1']",0.9999830567881718,0,0,8
309,Hepatitis C and Hepatocellular Carcinoma WP3646,0.5956579684938179,0.9697660586835845,0.5024247930216846,"['CDKN1A', 'JUN', 'TGFB1', 'RAC1', 'SOS1', 'TGFBR1', 'NFKB1', 'VAV2', 'MAPK3']",0.9999830567881718,0,0,9
310,22q11.2 copy number variation syndrome WP4657,0.5987918220747235,0.9643301300169588,0.4945483018075446,"['RTN4R', 'PRKN', 'RANBP1', 'RTL10', 'VWF', 'SERPIND1', 'KLHL22', 'EMC10', 'RTN4', 'SLC7A4', 'ACTA2', 'CYP26B1', 'MRPL40', 'ACTC1', 'THAP7', 'CLTCL1', 'RCC1', 'DGCR6L', 'HIST1H4C', 'RAN', 'FGF10']",0.9999830567881718,0,0,21
311,let-7 inhibition of ES cell reprogramming WP3299,0.5997736450517537,1.401,0.7161953374232011,['EGR1'],0.9999830567881718,0,0,1
312,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.5997736450517537,1.401,0.7161953374232011,['NRP1'],0.9999830567881718,0,0,1
313,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.5997736450517537,1.401,0.7161953374232011,['MAS1'],0.9999830567881718,0,0,1
314,Steroid Biosynthesis WP496,0.5997736450517537,1.401,0.7161953374232011,['HSD17B1'],0.9999830567881718,0,0,1
315,Kit receptor signaling pathway WP304,0.6031116300380899,0.9604716865249969,0.4856653656438133,"['MAP2K1', 'TEC', 'STAT1', 'BAD', 'RPS6', 'MITF', 'FOS', 'GAB2', 'JAK2', 'SOS1', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,12
316,Mesodermal commitment pathway WP2857,0.6092548484982204,0.9592193830099154,0.47531107297129566,"['MACF1', 'CTBP2', 'ACACA', 'PPP2CA', 'CSRP2', 'TRIM5', 'RPL38', 'ASCC3', 'AMH', 'JAK2', 'VAV3', 'SLC2A12', 'ELP4', 'ZFHX4', 'EXT1', 'CCDC88A', 'TOX3', 'ARL4A', 'KLF5', 'PRKAR1A', 'BHLHE40', 'NABP2', 'RARB', 'PLCH1', 'TOX']",0.9999830567881718,0,0,25
317,Regulation of toll-like receptor signaling pathway WP1449,0.6215586028924817,0.9494641613796931,0.45149402111656645,"['IFNAR2', 'MAP2K1', 'JUN', 'CUEDC2', 'TICAM2', 'STAT1', 'PELI3', 'PELI2', 'PIK3R3', 'PIK3CD', 'FOS', 'NFKB1', 'IRAK1', 'TRAF3', 'TOLLIP', 'MAP3K8', 'FADD', 'RAC1', 'TMED7', 'MAPK3']",0.9999830567881718,0,0,20
318,Small cell lung cancer WP4658,0.6215586028924817,0.9494641613796931,0.45149402111656645,"['CDKN1A', 'CDKN1B', 'LAMA2', 'LAMB3', 'GADD45B', 'GADD45A', 'LAMA4', 'LAMA3', 'FN1', 'PIK3CD', 'PIK3R3', 'FHIT', 'NFKB1', 'CKS1B', 'CCNE2', 'TRAF3', 'RARB', 'CYCS', 'BAX', 'SKP1']",0.9999830567881718,0,0,20
319,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6329134250847217,0.9337723065177975,0.4271276555480998,"['RPTOR', 'DEPTOR', 'MAP1LC3A', 'EIF2B2', 'IGFBP5', 'TNFSF9', 'NFKB1', 'IGF1R']",0.9999830567881718,0,0,8
320,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.6329134250847217,0.9337723065177975,0.4271276555480998,"['JUN', 'TRAF3', 'TNFSF12', 'FADD', 'RAC1', 'NFKB1', 'RELB', 'MAPK3']",0.9999830567881718,0,0,8
321,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.6331091860111725,0.9337533409698359,0.42683021385711606,"['IFNAR2', 'TGFB1', 'TRAF3', 'STAT1', 'TRADD', 'CXCL17', 'FADD', 'NFKB1', 'IFIT2']",0.9999830567881718,0,0,9
322,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.6344713569613414,0.9337153772683858,0.42480607574354495,"['PPP1CC', 'PPP1R3F', 'PPP1R14B', 'XBP1', 'MAP1LC3A', 'PPP1R11', 'HSPA5', 'PPP1R1A', 'DDIT3', 'PPP1R1B', 'ATF4']",0.9999830567881718,0,0,11
323,Interferon type I signaling pathways WP585,0.6344713569613414,0.9337153772683858,0.42480607574354495,"['RPTOR', 'IFNAR2', 'RPS6KA5', 'MAP3K1', 'STAT1', 'RPS6', 'RACK1', 'PIK3CD', 'RAC1', 'GAB2', 'EIF4B']",0.9999830567881718,0,0,11
324,EPO Receptor Signaling WP581,0.6365694989153833,0.9338291380625476,0.42177483524013587,"['MAP2K1', 'STAT1', 'JAK2', 'SOS1', 'MAPK3']",0.9999830567881718,0,0,5
325,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.6365694989153833,0.9338291380625476,0.42177483524013587,"['CEBPA', 'TTC9', 'CEBPB', 'PNCK', 'JAK2']",0.9999830567881718,0,0,5
326,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.6408103896406823,0.9338480602421123,0.41558262312038247,"['IFIH1', 'IFNAR2', 'STAT1', 'TRAF3']",0.9999830567881718,0,0,4
327,Airway smooth muscle cell contraction WP4962,0.6487092193412933,0.9338669716028206,0.4041502693932856,"['RYR1', 'CALM1', 'CALM2']",0.9999830567881718,0,0,3
328,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.6487092193412933,0.9338669716028206,0.4041502693932856,"['RYR1', 'RYR2', 'CCK']",0.9999830567881718,0,0,3
329,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.6487092193412933,0.9338669716028206,0.4041502693932856,"['PFKFB4', 'LDHA', 'SLC2A3']",0.9999830567881718,0,0,3
330,Endoderm differentiation WP2853,0.6539296664107279,0.9334484081319524,0.3964873238721315,"['CTBP2', 'TCF7', 'WNT8A', 'ACACA', 'TRIM5', 'TCEAL2', 'ASCC3', 'VAV3', 'DUSP4', 'DUSP5', 'DUSP2', 'TGFB1', 'STAT1', 'SLC2A12', 'ELP4', 'ZFHX4', 'NME1', 'EXT1', 'TOX3', 'DAB2', 'RFX7', 'NABP2', 'PLCH1', 'TOX', 'EZH2']",0.9999830567881718,0,0,25
331,15q13.3 copy number variation syndrome WP4942,0.6646174906577468,0.9338858721539487,0.38153310164986926,"['KAT2B', 'OTUD7A']",0.9999830567881718,0,0,2
332,Biomarkers for urea cycle disorders WP4583,0.6646174906577468,0.9338858721539487,0.38153310164986926,"['GOT1', 'GPT']",0.9999830567881718,0,0,2
333,Canonical NF-KB pathway WP4562,0.6646174906577468,0.9338858721539487,0.38153310164986926,"['NFKBIE', 'NFKB1']",0.9999830567881718,0,0,2
334,Farnesoid X receptor pathway WP2879,0.6646174906577468,0.9338858721539487,0.38153310164986926,"['SLC10A1', 'FKBP5']",0.9999830567881718,0,0,2
335,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.6646174906577468,0.9338858721539487,0.38153310164986926,"['ELOB', 'ELOC']",0.9999830567881718,0,0,2
336,Iron metabolism in placenta WP2007,0.6646174906577468,0.9338858721539487,0.38153310164986926,"['TF', 'FTH1']",0.9999830567881718,0,0,2
337,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.6646174906577468,0.9338858721539487,0.38153310164986926,"['TGFB1', 'NFKB1']",0.9999830567881718,0,0,2
338,DNA IR-double strand breaks and cellular response via ATM WP3959,0.666399452838196,0.908368385582487,0.3686758515406971,"['UPF1', 'DCLRE1C', 'PCNA', 'KAT5', 'CDK5', 'CDKN2A', 'H2AFX', 'ABL1', 'NABP2', 'BAX', 'MCPH1', 'RAD9A']",0.9999830567881718,0,0,12
339,Cytosolic DNA-sensing pathway WP4655,0.6674247038201792,0.9035214976760518,0.3653196710740855,"['TRADD', 'IL18', 'POLR2E', 'ISG15', 'POLR3H', 'FADD', 'POLR3K', 'POLR2K', 'NFKB1', 'POLR2L']",0.9999830567881718,0,0,10
340,Common Pathways Underlying Drug Addiction WP2636,0.6685934829496406,0.9003129602356407,0.3624471383518782,"['PRKCG', 'PPP1CC', 'MAP2K1', 'PPP1R1A', 'CALM1', 'CALM2', 'ACTB', 'ACTG1', 'MAPK3']",0.9999830567881718,0,0,9
341,B Cell Receptor Signaling Pathway WP23,0.6686987368901863,0.9165139769790932,0.3688250566242847,"['MAP2K1', 'JUN', 'GSK3A', 'CD81', 'PRKCD', 'NFATC3', 'GAB1', 'GAB2', 'ELK1', 'ILF2', 'NFKB1', 'VAV2', 'TEC', 'PIP5K1B', 'RAC1', 'SOS1', 'HRAS', 'MEF2D']",0.9999830567881718,0,0,18
342,Amyotrophic lateral sclerosis (ALS) WP2447,0.6703974977495518,0.896329802462067,0.35842836109657056,"['BAD', 'DERL1', 'NEFL', 'BAX', 'NEFM', 'RAC1', 'NEFH', 'SOD1']",0.9999830567881718,0,0,8
343,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6703974977495518,0.896329802462067,0.35842836109657056,"['MAP2K1', 'JUN', 'MAP3K1', 'IFI27', 'RPS6KA2', 'DDIT3', 'FOS', 'MAPK3']",0.9999830567881718,0,0,8
344,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.6703974977495518,0.896329802462067,0.35842836109657056,"['GABRA1', 'GABRB1', 'SLC12A5', 'BDNF', 'PIK3R3', 'JAK2', 'GABRD', 'GABRG3']",0.9999830567881718,0,0,8
345,Melatonin metabolism and effects WP3298,0.6730755750387574,0.8912551386792944,0.35284582377126056,"['PER2', 'IRAK1', 'CYP1B1', 'ADRB1', 'CALM1', 'CALM2', 'NFKB1']",0.9999830567881718,0,0,7
346,IL17 signaling pathway WP2112,0.6770000377689033,0.8845719448836684,0.34505731856817407,"['CEBPB', 'TRAF3', 'IL17RE', 'JAK2', 'NFKB1', 'MAPK3']",0.9999830567881718,0,0,6
347,Ebstein-Barr virus LMP1 signaling WP262,0.6915433508989541,0.861925606563868,0.31790353770247476,"['HSP90AA1', 'IRAK1', 'TRADD', 'NFKB1']",0.9999830567881718,0,0,4
348,Hippo-Yap signaling pathway WP4537,0.6915433508989541,0.861925606563868,0.31790353770247476,"['YWHAQ', 'NF2', 'TNIK', 'NDRG1']",0.9999830567881718,0,0,4
349,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.6915433508989541,0.861925606563868,0.31790353770247476,"['RAB5C', 'RRAS2', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,4
350,Amino Acid metabolism WP3925,0.6929683094332366,0.8981868596061781,0.32942890200009955,"['WARS', 'HIBADH', 'GOT1', 'MDH2', 'MARS2', 'ODC1', 'GOT2', 'ADH5', 'SRM', 'ACLY', 'LDHA', 'PKM', 'TDO2', 'CPS1', 'P4HA2', 'ALDH1A1', 'HIBCH']",0.9999830567881718,0,0,17
351,ErbB signaling pathway WP673,0.6934264684607391,0.9032443402433487,0.33068685266712644,"['PRKCG', 'SHC4', 'CDKN1A', 'MAP2K1', 'JUN', 'CDKN1B', 'BAD', 'EGF', 'GAB1', 'PIK3CD', 'PIK3R3', 'NRG1', 'NRG2', 'ELK1', 'BCL2L11', 'NRG3', 'ABL1', 'SOS1', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,20
352,Eukaryotic Transcription Initiation WP405,0.6993018215683217,0.8751969349756517,0.3130341727935277,"['TAF13', 'POLR2C', 'POLR2E', 'POLR1E', 'TAF7', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.9999830567881718,0,0,10
353,MAPK Signaling Pathway WP382,0.7025880229632976,0.926585841345401,0.32707051963013317,"['FGF1', 'ELK1', 'RPS6KA5', 'STMN1', 'RAC3', 'MAP3K8', 'RAC1', 'HRAS', 'PRKCG', 'DUSP4', 'DUSP2', 'MAP2K1', 'DUSP3', 'DUSP1', 'PRKCD', 'CACNA2D3', 'RRAS2', 'FOS', 'DUSP6', 'TGFBR1', 'DUSP7', 'DDIT3', 'SOS1', 'ATF4', 'CACNA1B', 'CACNA1A', 'CACNA1C', 'RELB', 'FLNB', 'CACNG2', 'MAP2K5', 'MAPK3', 'HSPA8', 'JUN', 'JUND', 'MAP3K1', 'TGFB1', 'HSPA1L', 'GADD45A', 'BDNF', 'EGF', 'NFATC3', 'NFKB1', 'FGF17', 'NR4A1', 'FGF14', 'LAMTOR3', 'FGF12', 'FGF10']",0.9999830567881718,0,0,49
354,Fatty Acid Omega Oxidation WP206,0.7050707700707665,0.9339047619047619,0.32635964802391637,['ALDH1A1'],0.9999830567881718,0,0,1
355,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.7050707700707665,0.9339047619047619,0.32635964802391637,['GGCT'],0.9999830567881718,0,0,1
356,Role of Osx and miRNAs in tooth development WP3971,0.7050707700707665,0.9339047619047619,0.32635964802391637,['NOTCH4'],0.9999830567881718,0,0,1
357,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.7050707700707665,0.9339047619047619,0.32635964802391637,['DLL3'],0.9999830567881718,0,0,1
358,Biomarkers for pyrimidine metabolism disorders WP4584,0.7054941051765883,0.8403945111492281,0.2931773930519688,"['NT5C', 'DPYS', 'CKB']",0.9999830567881718,0,0,3
359,"GPCRs, Class B Secretin-like WP334",0.7054941051765883,0.8403945111492281,0.2931773930519688,"['CALCRL', 'ADGRG2', 'PTH1R']",0.9999830567881718,0,0,3
360,IL-9 signaling pathway WP22,0.7054941051765883,0.8403945111492281,0.2931773930519688,"['MAP2K1', 'STAT1', 'MAPK3']",0.9999830567881718,0,0,3
361,miRNA targets in ECM and membrane receptors WP2911,0.7054941051765883,0.8403945111492281,0.2931773930519688,"['LAMA4', 'COL5A2', 'FN1']",0.9999830567881718,0,0,3
362,PPAR-alpha pathway WP2878,0.7054941051765883,0.8403945111492281,0.2931773930519688,"['CPT2', 'APOA1', 'PPARA']",0.9999830567881718,0,0,3
363,Bladder cancer WP2828,0.7100984613761324,0.8524178094124089,0.2918266355009751,"['CDKN1A', 'MAP2K1', 'RPS6KA5', 'EGF', 'CDKN2A', 'DAPK2', 'HRAS']",0.9999830567881718,0,0,7
364,Nanoparticle-mediated activation of receptor signaling WP2643,0.7163268247221302,0.8402575107296137,0.28032566633837985,"['MAP2K1', 'PXN', 'FN1', 'PIK3CD', 'SOS1', 'HRAS']",0.9999830567881718,0,0,6
365,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7176099525834281,0.8784313725490196,0.2914890909480379,"['MAP2K1', 'THRA', 'BAD', 'RPS6', 'DIO1', 'ITPR2', 'SLC16A10', 'TSHR', 'RPTOR', 'CREB3', 'TBC1D4', 'ZNF516', 'PRKCQ', 'PPARG', 'SOS1', 'HRAS']",0.9999830567881718,0,0,16
366,Head and Neck Squamous Cell Carcinoma WP4674,0.7199142266199917,0.871146799222509,0.2862790521083818,"['CDKN1A', 'CDKN2A', 'RPS6', 'GAB1', 'KEAP1', 'NFKB1', 'IGF1R', 'RPTOR', 'FKBP1A', 'TRAF3', 'DDIT4', 'FADD', 'CSMD3', 'HRAS']",0.9999830567881718,0,0,14
367,Estrogen signaling pathway WP712,0.7248601764193598,0.8237986270022883,0.26507904124003073,"['MAP2K1', 'JUN', 'FOS', 'ELK1', 'NFKB1']",0.9999830567881718,0,0,5
368,Physiological and pathological hypertrophy of the heart WP1528,0.7248601764193598,0.8237986270022883,0.26507904124003073,"['JUN', 'RAC1', 'FOS', 'CALM1', 'CALM2']",0.9999830567881718,0,0,5
369,Unfolded protein response WP4925,0.7248601764193598,0.8237986270022883,0.26507904124003073,"['XBP1', 'BCL2L11', 'HSPA5', 'DDIT3', 'ATF4']",0.9999830567881718,0,0,5
370,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.7291979177387782,0.8485890124389122,0.26799297385405674,"['ADCY10', 'MAP2K1', 'TGFB1', 'ADCY9', 'CFL1', 'BANF1', 'SOS1', 'HRAS', 'EMD', 'MAPK3']",0.9999830567881718,0,0,10
371,Modulators of TCR signaling and T cell activation WP5072,0.7291979177387782,0.8485890124389122,0.26799297385405674,"['FIBP', 'CDKN1B', 'NDUFB10', 'ELOB', 'MAP3K8', 'PRKCQ', 'LCP2', 'RNF7', 'MEF2D', 'NFKB1']",0.9999830567881718,0,0,10
372,Genes targeted by miRNAs in adipocytes WP1992,0.7299854606102785,0.8003919487200425,0.25190788788834667,"['TMSB4X', 'KCNJ2']",0.9999830567881718,0,0,2
373,Glutathione metabolism WP100,0.7299854606102785,0.8003919487200425,0.25190788788834667,"['GPX4', 'GPX3']",0.9999830567881718,0,0,2
374,Matrix Metalloproteinases WP129,0.7299854606102785,0.8003919487200425,0.25190788788834667,"['TIMP2', 'TIMP3']",0.9999830567881718,0,0,2
375,miR-509-3p alteration of YAP1/ECM axis WP3967,0.7299854606102785,0.8003919487200425,0.25190788788834667,"['SPARC', 'FN1']",0.9999830567881718,0,0,2
376,Neuroinflammation WP4919,0.7299854606102785,0.8003919487200425,0.25190788788834667,"['JUN', 'FOS']",0.9999830567881718,0,0,2
377,Purine metabolism WP4792,0.7299854606102785,0.8003919487200425,0.25190788788834667,"['PRPS1', 'APRT']",0.9999830567881718,0,0,2
378,Thiamine metabolic pathways WP4297,0.7299854606102785,0.8003919487200425,0.25190788788834667,"['BCKDK', 'SLC19A3']",0.9999830567881718,0,0,2
379,Heart Development WP1591,0.7369413562805337,0.8002777891253727,0.24428236293652406,"['HEY1', 'BHLHE40', 'NFATC3', 'FGF10']",0.9999830567881718,0,0,4
380,miRNAs involvement in the immune response in sepsis WP4329,0.7369413562805337,0.8002777891253727,0.24428236293652406,"['IRAK1', 'TRAF3', 'NFKB1', 'RELB']",0.9999830567881718,0,0,4
381,NAD+ biosynthetic pathways WP3645,0.7369413562805337,0.8002777891253727,0.24428236293652406,"['NMNAT1', 'TDO2', 'NADSYN1', 'ACMSD']",0.9999830567881718,0,0,4
382,Nucleotide metabolism WP404,0.7369413562805337,0.8002777891253727,0.24428236293652406,"['PRPS1', 'NME2', 'OAZ1', 'SRM']",0.9999830567881718,0,0,4
383,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7369413562805337,0.8002777891253727,0.24428236293652406,"['PTGES2', 'PIK3CD', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,4
384,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.7369413562805337,0.8002777891253727,0.24428236293652406,"['MAP2K1', 'ELK1', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,4
385,EGF/EGFR signaling pathway WP437,0.7373002533068802,0.8995361781076067,0.2741427089912284,"['NDUFA13', 'PCNA', 'PEBP1', 'NEDD8', 'FOXO4', 'ELK1', 'RPS6KA5', 'RPS6KA2', 'CFL1', 'STMN1', 'ABL1', 'AP2S1', 'RAC1', 'JAK2', 'HRAS', 'MEF2D', 'AP2M1', 'MAP2K5', 'VAV3', 'MAP2K1', 'JUN', 'JUND', 'MAP3K1', 'CAV2', 'STAT1', 'EGF', 'LIMK2', 'PRKCD', 'GAB1', 'FOS', 'GAB2', 'EPN1', 'VAV2', 'SPRY2', 'SOS1', 'ARF6']",0.9999830567881718,0,0,36
386,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7379898089059881,0.829765350807435,0.2521036763916424,"['JUN', 'MAP3K1', 'CASP6', 'LMNA', 'CYCS', 'FADD', 'ACTB', 'ACTG1']",0.9999830567881718,0,0,8
387,Glioblastoma signaling pathways WP2261,0.7383950068875021,0.8688407734117437,0.26349886534349126,"['PRKCG', 'PDGFRA', 'CDKN1A', 'MAP2K1', 'CDKN1B', 'PRKCH', 'CDKN2C', 'CDKN2A', 'PRKCD', 'GAB1', 'PIK3CD', 'FOXO4', 'IGF1R', 'SPRY2', 'PRKCQ', 'HRAS', 'MAP2K5', 'MAPK3']",0.9999830567881718,0,0,18
388,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.7408901888948773,0.8614501710627966,0.2583513681471901,"['FZD1', 'MAP2K1', 'TGFB1', 'EGF', 'PIK3CD', 'PIK3R3', 'NRG1', 'HDAC9', 'NFKB1', 'IGF1R', 'RAC1', 'CALM1', 'PLCB2', 'CALM2', 'MAP2K5', 'MAPK3']",0.9999830567881718,0,0,16
389,T-cell receptor (TCR) signaling pathway WP69,0.7425299664251059,0.8570726052899645,0.25514370112300616,"['VAV3', 'MAP2K1', 'JUN', 'TGFB1', 'PRKCD', 'FOS', 'GAB2', 'NFKB1', 'MAP3K8', 'PRKCQ', 'LCP2', 'SOS1', 'HRAS', 'SKAP1', 'MAPK3']",0.9999830567881718,0,0,15
390,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.752206779633279,0.8001634988759452,0.2278417712582492,"['ACTA2', 'TGFB1', 'BAX', 'PRKCQ', 'TGFBR1', 'MCU']",0.9999830567881718,0,0,6
391,Eicosanoid Synthesis WP167,0.7549492406650443,0.7639170435053797,0.21474071939018272,"['PTGES2', 'ALOX12', 'PTGES']",0.9999830567881718,0,0,3
392,Pyrimidine metabolism and related diseases WP4225,0.7549492406650443,0.7639170435053797,0.21474071939018272,"['NT5C', 'CPS1', 'DPYS']",0.9999830567881718,0,0,3
393,Nucleotide Excision Repair WP4753,0.757058642268321,0.8235462618160986,0.22920491704214932,"['POLE4', 'POLD4', 'PCNA', 'CETN2', 'RPA3', 'POLE2', 'POLD2', 'POLE3', 'RPA2', 'RAD23A']",0.9999830567881718,0,0,10
394,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.757058642268321,0.8235462618160986,0.22920491704214932,"['MAP2K1', 'RPS6KA5', 'MAP3K1', 'IRAK1', 'TOLLIP', 'MAP3K8', 'FOS', 'ELK1', 'NFKB1', 'MAPK3']",0.9999830567881718,0,0,10
395,Histone Modifications WP2369,0.7619633612550732,0.8129364815430662,0.22100231599857206,"['SET', 'SETBP1', 'H3F3B', 'SUV39H1', 'H3F3A', 'EHMT1', 'SMYD3', 'HIST1H4C', 'EZH2']",0.9999830567881718,0,0,9
396,16p11.2 distal deletion syndrome WP4950,0.7627536563113557,0.7779525807271803,0.2106852437899945,"['PLN', 'CD81', 'JAK2', 'TUFM', 'VAV2']",0.9999830567881718,0,0,5
397,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.7627536563113557,0.7779525807271803,0.2106852437899945,"['YWHAQ', 'LPL', 'FOXO4', 'RAC1', 'NDRG1']",0.9999830567881718,0,0,5
398,G13 Signaling Pathway WP524,0.7753615473092952,0.7840641099026904,0.1994861742880027,"['CFL2', 'CFL1', 'ARHGDIG', 'PIK3CD', 'RAC1', 'CALM1', 'CALM2']",0.9999830567881718,0,0,7
399,Vitamin D-sensitive calcium signaling in depression WP4698,0.7753615473092952,0.7840641099026904,0.1994861742880027,"['CYP27A1', 'CHRM1', 'CALB1', 'GPX4', 'KCNQ3', 'ITPR2', 'CACNA1C']",0.9999830567881718,0,0,7
400,ESC Pluripotency Pathways WP3931,0.7759708815330884,0.8481540483838674,0.21512603311456724,"['FZD1', 'PDGFRA', 'MAP2K1', 'JUN', 'EGF', 'GAB1', 'PIK3CD', 'WNT7A', 'FOS', 'FGF1', 'ELK1', 'FGF17', 'FGF14', 'BMPR1B', 'SOS1', 'WNT2', 'FGF12', 'HRAS', 'MAP2K5', 'FGF10']",0.9999830567881718,0,0,20
401,Gastric Cancer Network 1 WP2361,0.7770864065677935,0.746849680678677,0.18835827479330036,"['H3F3A', 'MCM4', 'GATD3B', 'GATD3A']",0.9999830567881718,0,0,4
402,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.7770864065677935,0.746849680678677,0.18835827479330036,"['BCL2L11', 'BAD', 'BAX', 'FADD']",0.9999830567881718,0,0,4
403,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.7826705888450644,0.7003571428571429,0.17161787828075784,['IRAK1'],0.9999830567881718,0,0,1
404,Complement Activation WP545,0.7826705888450644,0.7003571428571429,0.17161787828075784,['C2'],0.9999830567881718,0,0,1
405,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.7826705888450644,0.7003571428571429,0.17161787828075784,['ELOVL2'],0.9999830567881718,0,0,1
406,Metabolism of alpha-linolenic acid WP4586,0.7826705888450644,0.7003571428571429,0.17161787828075784,['ALOX12'],0.9999830567881718,0,0,1
407,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.7826705888450644,0.7003571428571429,0.17161787828075784,['HEY1'],0.9999830567881718,0,0,1
408,SARS-CoV-2 and COVID-19 Pathway WP4846,0.7826705888450644,0.7003571428571429,0.17161787828075784,['NRP1'],0.9999830567881718,0,0,1
409,Small Ligand GPCRs WP247,0.7826705888450644,0.7003571428571429,0.17161787828075784,['PTGDR'],0.9999830567881718,0,0,1
410,Somatic sex determination WP4814,0.7826705888450644,0.7003571428571429,0.17161787828075784,['AMH'],0.9999830567881718,0,0,1
411,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.7826705888450644,0.7003571428571429,0.17161787828075784,['IGF1R'],0.9999830567881718,0,0,1
412,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.7826705888450644,0.7003571428571429,0.17161787828075784,['MAPK3'],0.9999830567881718,0,0,1
413,The alternative pathway of fetal androgen synthesis WP4524,0.7826705888450644,0.7003571428571429,0.17161787828075784,['STAR'],0.9999830567881718,0,0,1
414,Vitamin D Metabolism WP1531,0.7826705888450644,0.7003571428571429,0.17161787828075784,['CYP27A1'],0.9999830567881718,0,0,1
415,Cysteine and methionine catabolism WP4504,0.7841790317245985,0.7002715061446128,0.17024855754800805,"['AHCY', 'GOT1']",0.9999830567881718,0,0,2
416,ID signaling pathway WP53,0.7841790317245985,0.7002715061446128,0.17024855754800805,"['RBL1', 'ELK1']",0.9999830567881718,0,0,2
417,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.7841790317245985,0.7002715061446128,0.17024855754800805,"['TGFB1', 'NFKB1']",0.9999830567881718,0,0,2
418,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.7841790317245985,0.7002715061446128,0.17024855754800805,"['IDI1', 'PMVK']",0.9999830567881718,0,0,2
419,Non-homologous end joining WP438,0.7841790317245985,0.7002715061446128,0.17024855754800805,"['XRCC6', 'DCLRE1C']",0.9999830567881718,0,0,2
420,Autophagy WP4923,0.7846549828080375,0.763714397190792,0.18520927213080757,"['RPTOR', 'MAP1LC3B', 'DEPTOR', 'ATG101', 'ATG9A', 'WIPI2']",0.9999830567881718,0,0,6
421,Prion disease pathway WP3995,0.7846549828080375,0.763714397190792,0.18520927213080757,"['PRNP', 'HSPA5', 'ELK1', 'NFKB1', 'HSP90B1', 'MAPK3']",0.9999830567881718,0,0,6
422,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7885523268107019,0.787451675257732,0.18706427358452749,"['PDGFRA', 'CDKN1A', 'HSP90AA1', 'JUN', 'BCL2L11', 'CDKN2A', 'BAX', 'FOS', 'ELK1']",0.9999830567881718,0,0,9
423,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7966918717511331,0.7998198419522581,0.18178888040151273,"['ANGPT2', 'BAD', 'STMN1', 'PXN', 'FN1', 'BAX', 'RAC1', 'SOS1', 'HRAS', 'ANGPTL1', 'NFKB1', 'MAPK3']",0.9999830567881718,0,0,12
424,Cholesterol Biosynthesis Pathway WP197,0.7974674011924954,0.7001858204688394,0.15846207881768284,"['IDI1', 'PMVK', 'MSMO1']",0.9999830567881718,0,0,3
425,Overview of interferons-mediated signaling pathway WP4558,0.7974674011924954,0.7001858204688394,0.15846207881768284,"['IFNAR2', 'STAT1', 'JAK2']",0.9999830567881718,0,0,3
426,Ectoderm Differentiation WP2858,0.8031633349384926,0.8427842555492395,0.18473593201188113,"['NLGN1', 'CTNND2', 'ARHGDIG', 'LDB2', 'JAKMIP1', 'CELSR2', 'CDH6', 'TRPM2', 'ST8SIA4', 'TBL1X', 'CTNNA2', 'ANKS1B', 'CDON', 'CLVS1', 'TTC14', 'BCAS3', 'ELOVL2', 'SORCS1', 'ZFHX4', 'TOX3', 'PLCXD3', 'PPFIBP2', 'SPRY2', 'NF2', 'LY6E']",0.9999830567881718,0,0,25
427,Allograft Rejection WP2328,0.8036210609894366,0.7538307428118532,0.16480808405092498,"['PDGFRA', 'ABCB1', 'TGFB1', 'STAT1', 'HLA-C', 'HLA-DQB1', 'C2']",0.9999830567881718,0,0,7
428,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.8122155793982772,0.7001000857878181,0.14561345432235528,"['BDNF', 'FSHR', 'RPS6', 'MAPK3']",0.9999830567881718,0,0,4
429,Genes controlling nephrogenesis WP4823,0.8122155793982772,0.7001000857878181,0.14561345432235528,"['EYA1', 'SLIT2', 'CD36', 'ETV4']",0.9999830567881718,0,0,4
430,NRF2-ARE regulation WP4357,0.8122155793982772,0.7001000857878181,0.14561345432235528,"['AIMP2', 'CEBPB', 'KEAP1', 'SLC7A11']",0.9999830567881718,0,0,4
431,PKC-gamma calcium signaling pathway in ataxia WP4760,0.8122155793982772,0.7001000857878181,0.14561345432235528,"['PRKCG', 'CACNA1A', 'CA8', 'PLCB2']",0.9999830567881718,0,0,4
432,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8122155793982772,0.7001000857878181,0.14561345432235528,"['GSK3A', 'CALM1', 'CALM2', 'NFKB1']",0.9999830567881718,0,0,4
433,DNA damage response WP707,0.8176656204201296,0.7811393949089164,0.15724476854574002,"['CDKN1A', 'CDKN1B', 'CCNE2', 'GADD45B', 'CDK5', 'GADD45A', 'H2AFX', 'ABL1', 'RPA2', 'CYCS', 'BAX', 'RAD9A']",0.9999830567881718,0,0,12
434,MET in type 1 papillary renal cell carcinoma WP4205,0.8176656204201296,0.7811393949089164,0.15724476854574002,"['CDKN1A', 'MAP2K1', 'JUN', 'BAD', 'RPL11', 'GAB1', 'PIK3CD', 'PIK3R3', 'RAC1', 'SOS1', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,12
435,Wnt signaling WP428,0.8182480482943866,0.8063496078927397,0.16174546692334413,"['PRKCG', 'FZD1', 'JUN', 'CTBP2', 'SERPINF1', 'TCF7', 'NFATC3', 'WNT7A', 'CXXC4', 'FRAT1', 'FRAT2', 'SFRP2', 'CSNK2B', 'ROR1', 'RAC1', 'WNT2', 'PLCB2']",0.9999830567881718,0,0,17
436,AGE/RAGE pathway WP2324,0.8226666420568505,0.7697636103151863,0.1502610993932587,"['MAP2K1', 'JUN', 'STAT1', 'PRKCD', 'CYCS', 'RAC1', 'FOXO4', 'JAK2', 'NFKB1', 'MAPK3', 'SOD1']",0.9999830567881718,0,0,11
437,p53 transcriptional gene network WP4963,0.8284105734061253,0.7565399831226242,0.14241591760715325,"['BTG2', 'CDKN1A', 'DRAM1', 'SIVA1', 'ZMAT3', 'GADD45A', 'SLC2A1', 'BAX', 'ISG15', 'SLC7A11']",0.9999830567881718,0,0,10
438,FOXA2 pathway WP5066,0.8285525446563416,0.6224000508081674,0.11705790368090259,"['MLXIPL', 'ACACA']",0.9999830567881718,0,0,2
439,Homologous recombination WP186,0.8285525446563416,0.6224000508081674,0.11705790368090259,"['POLD4', 'POLD2']",0.9999830567881718,0,0,2
440,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.8285525446563416,0.6224000508081674,0.11705790368090259,"['MAP3K1', 'NFKB1']",0.9999830567881718,0,0,2
441,ATM Signaling Pathway WP2516,0.8290710049245222,0.7258368843944116,0.1360577437998281,"['CDKN1A', 'JUN', 'CRADD', 'GADD45A', 'H2AFX', 'ABL1', 'RAD9A']",0.9999830567881718,0,0,7
442,NO/cGMP/PKG mediated Neuroprotection WP4008,0.8290710049245222,0.7258368843944116,0.1360577437998281,"['BAD', 'PDE3A', 'NEFL', 'CYCS', 'CALM1', 'CALM2', 'NFKB1']",0.9999830567881718,0,0,7
443,G Protein Signaling Pathways WP35,0.8320485264274456,0.7994750010253886,0.14699508318127105,"['PRKCG', 'GNAZ', 'PRKCH', 'PDE4D', 'PDE1A', 'PRKCD', 'AKAP5', 'GNG10', 'GNG3', 'ADCY9', 'PRKD3', 'PRKAR1A', 'PRKCQ', 'PRKD1', 'PDE7B', 'CALM1', 'HRAS', 'CALM2']",0.9999830567881718,0,0,18
444,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.8336189545733289,0.6462594009763821,0.1176055555358025,"['CNP', 'OMG', 'SOX5']",0.9999830567881718,0,0,3
445,Statin inhibition of cholesterol production WP430,0.8336189545733289,0.6462594009763821,0.1176055555358025,"['ABCG8', 'LPL', 'APOA1']",0.9999830567881718,0,0,3
446,Transcription factor regulation in adipogenesis WP3599,0.8336189545733289,0.6462594009763821,0.1176055555358025,"['CEBPA', 'CEBPB', 'PPARG']",0.9999830567881718,0,0,3
447,Benzo(a)pyrene metabolism WP696,0.8398570434708714,0.5602285714285714,0.0977731003703201,['CYP1B1'],0.9999830567881718,0,0,1
448,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.8398570434708714,0.5602285714285714,0.0977731003703201,['BCL2L11'],0.9999830567881718,0,0,1
449,miRNA Biogenesis WP2338,0.8398570434708714,0.5602285714285714,0.0977731003703201,['RAN'],0.9999830567881718,0,0,1
450,Pilocytic astrocytoma WP2253,0.8398570434708714,0.5602285714285714,0.0977731003703201,['SOS1'],0.9999830567881718,0,0,1
451,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.8398570434708714,0.5602285714285714,0.0977731003703201,['NFKB1'],0.9999830567881718,0,0,1
452,Selective expression of chemokine receptors during T-cell polarization WP4494,0.8398570434708714,0.5602285714285714,0.0977731003703201,['TGFB1'],0.9999830567881718,0,0,1
453,Serotonin Transporter Activity WP1455,0.8398570434708714,0.5602285714285714,0.0977731003703201,['PPP2CB'],0.9999830567881718,0,0,1
454,Vitamin B12 Disorders WP4271,0.8398570434708714,0.5602285714285714,0.0977731003703201,['CUBN'],0.9999830567881718,0,0,1
455,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8426692468946125,0.6588504432370603,0.11278251328050393,"['TGFBR3', 'TGFB1', 'HRAS', 'TGFBR1']",0.9999830567881718,0,0,4
456,Fatty Acid Biosynthesis WP357,0.8426692468946125,0.6588504432370603,0.11278251328050393,"['ACLY', 'ACSL5', 'ACACB', 'ACACA']",0.9999830567881718,0,0,4
457,Notch Signaling Pathway Netpath WP61,0.8482529606453959,0.7365556543894828,0.12121966696969691,"['PSENEN', 'CDKN1A', 'JAG1', 'MAML2', 'HEY1', 'NOTCH4', 'JAK2', 'NFKB1', 'SKP1', 'DLL3']",0.9999830567881718,0,0,10
458,Copper homeostasis WP3286,0.851841264615834,0.6998425872925015,0.11222331312571772,"['PRNP', 'JUN', 'ATP7B', 'SCO2', 'COX17', 'ATOX1', 'SOD1']",0.9999830567881718,0,0,7
459,Glycerophospholipid Biosynthetic Pathway WP2533,0.8526625189098299,0.6666121826304893,0.10625228236126455,"['PTPMT1', 'PIK3CD', 'GPAT3', 'GPAT2', 'CDIPT']",0.9999830567881718,0,0,5
460,Oxysterols derived from cholesterol WP4545,0.8526625189098299,0.6666121826304893,0.10625228236126455,"['CYP39A1', 'CYP27A1', 'DBP', 'ACOT11', 'ACOT4']",0.9999830567881718,0,0,5
461,AMP-activated protein kinase (AMPK) signaling WP1403,0.8546920826127209,0.7462692270946785,0.11717472553159541,"['GYS2', 'RPTOR', 'GYS1', 'CDKN1A', 'LEPR', 'PIK3CD', 'PIK3R3', 'ADIPOR1', 'EEF2', 'CPT1B', 'ACACB', 'ACACA']",0.9999830567881718,0,0,12
462,miRNA regulation of DNA damage response WP1530,0.8546920826127209,0.7462692270946785,0.11717472553159541,"['CDKN1A', 'CDKN1B', 'CCNE2', 'GADD45B', 'CDK5', 'GADD45A', 'H2AFX', 'ABL1', 'RPA2', 'CYCS', 'BAX', 'RAD9A']",0.9999830567881718,0,0,12
463,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.8629756052306388,0.6997566561694818,0.10312233768948637,"['RPTOR', 'DEPTOR', 'MAP1LC3A', 'ATG101', 'WIPI2', 'GTPBP2', 'ACACA', 'FTL']",0.9999830567881718,0,0,8
464,Constitutive Androstane Receptor Pathway WP2875,0.8640636615839073,0.6000367556971331,0.08767066863415066,"['HSP90AA1', 'ABCB1', 'CYP3A5']",0.9999830567881718,0,0,3
465,Purine metabolism and related disorders WP4224,0.8640636615839073,0.6000367556971331,0.08767066863415066,"['PRPS1', 'PFAS', 'APRT']",0.9999830567881718,0,0,3
466,Canonical and non-canonical TGF-B signaling WP3874,0.8645211286958072,0.5601028865390112,0.08153951709798479,"['TGFB1', 'TGFBR1']",0.9999830567881718,0,0,2
467,Cell Differentiation - Index expanded WP2023,0.8645211286958072,0.5601028865390112,0.08153951709798479,"['MEF2D', 'EZH2']",0.9999830567881718,0,0,2
468,NOTCH1 regulation of endothelial cell calcification WP3413,0.8645211286958072,0.5601028865390112,0.08153951709798479,"['JAG1', 'DLL3']",0.9999830567881718,0,0,2
469,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.8645211286958072,0.5601028865390112,0.08153951709798479,"['FZD1', 'DKK3']",0.9999830567881718,0,0,2
470,Hippo-Merlin Signaling Dysregulation WP4541,0.8647846556333422,0.7670965890152217,0.11143976985073556,"['PDGFRA', 'ITGA4', 'FLT3', 'IGF1R', 'CDH7', 'CDH6', 'PPP1CC', 'CDH4', 'PRKAR1A', 'CDH20', 'ITGA10', 'CDH11', 'CDH12', 'NF2', 'HRAS', 'CDH18', 'ITGA9']",0.9999830567881718,0,0,17
471,Insulin Signaling WP481,0.868640684765866,0.8164865113145727,0.11498230123913274,"['ARF1', 'GSK3A', 'STXBP2', 'SLC2A1', 'PIK3R3', 'PIK3CD', 'ELK1', 'IGF1R', 'GYS2', 'GYS1', 'RPS6KA5', 'RPS6KA2', 'ENPP1', 'MAP3K8', 'RAC1', 'HRAS', 'MAP2K5', 'MAPK3', 'EGR1', 'MAP2K1', 'XBP1', 'JUN', 'PRKCH', 'MAP3K1', 'PRKCD', 'GAB1', 'FOS', 'EHD2', 'TBC1D4', 'PRKCQ', 'SOS1', 'PFKM', 'ARF6']",0.9999830567881718,0,0,33
472,MTHFR deficiency WP4288,0.8688489848309153,0.6221840943030534,0.0874703414871914,"['CHDH', 'DNMT3A', 'EHMT1', 'CYCS']",0.9999830567881718,0,0,4
473,Corticotropin-releasing hormone signaling pathway WP2355,0.8719749542645887,0.7494006638800098,0.1026638274458288,"['GNAZ', 'HSP90AA1', 'MAP2K1', 'TGFB1', 'JUND', 'PRKCD', 'IL18', 'FOS', 'ELK1', 'ACACA', 'NFKB1', 'NR4A1', 'STAR', 'PRKCQ', 'MAPK3']",0.9999830567881718,0,0,15
474,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.873161247743445,0.6996706758304696,0.09489985652043625,"['RPTOR', 'ARC', 'GRIN3A', 'BDNF', 'PIK3CD', 'PIK3R3', 'CACNA1C', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,9
475,Neural Crest Differentiation WP2064,0.8763561038752012,0.7158392750049977,0.09447844278487993,"['CDH6', 'CTBP2', 'NOTCH4', 'WNT8A', 'MITF', 'HDAC9', 'NFKB1', 'CDH7', 'SOX5', 'RHOB', 'DLL3']",0.9999830567881718,0,0,11
476,ATM Signaling Network in Development and Disease  WP3878,0.8810175756244816,0.6784825061378168,0.08594860582010624,"['DCLRE1C', 'KAT5', 'ATMIN', 'CDK5', 'H2AFX', 'NFKB1', 'HMGN1', 'CDK5R1']",0.9999830567881718,0,0,8
477,Splicing factor NOVA regulated synaptic proteins WP4148,0.8810175756244816,0.6784825061378168,0.08594860582010624,"['EPB41', 'CAV2', 'APLP2', 'CLSTN1', 'STXBP2', 'GRIK2', 'NCDN', 'EFNA5']",0.9999830567881718,0,0,8
478,Cell Differentiation - Index WP2029,0.8819989227057858,0.4668095238095238,0.05861467849688599,['MEF2D'],0.9999830567881718,0,0,1
479,"Cerebral organic acidurias, including diseases WP4519",0.8819989227057858,0.4668095238095238,0.05861467849688599,['MDH2'],0.9999830567881718,0,0,1
480,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.8819989227057858,0.4668095238095238,0.05861467849688599,['DHCR24'],0.9999830567881718,0,0,1
481,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.8819989227057858,0.4668095238095238,0.05861467849688599,['BATF3'],0.9999830567881718,0,0,1
482,Disorders of Folate Metabolism and Transport WP4259,0.8819989227057858,0.4668095238095238,0.05861467849688599,['SLC46A1'],0.9999830567881718,0,0,1
483,Disorders of the Krebs cycle WP4236,0.8819989227057858,0.4668095238095238,0.05861467849688599,['DHTKD1'],0.9999830567881718,0,0,1
484,Estrogen metabolism WP697,0.8819989227057858,0.4668095238095238,0.05861467849688599,['CYP1B1'],0.9999830567881718,0,0,1
485,Glial Cell Differentiation WP2276,0.8819989227057858,0.4668095238095238,0.05861467849688599,['CNP'],0.9999830567881718,0,0,1
486,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.8819989227057858,0.4668095238095238,0.05861467849688599,['STAT1'],0.9999830567881718,0,0,1
487,Inflammatory Response Pathway WP453,0.8819989227057858,0.4668095238095238,0.05861467849688599,['FN1'],0.9999830567881718,0,0,1
488,Liver X receptor pathway WP2874,0.8819989227057858,0.4668095238095238,0.05861467849688599,['ABCG8'],0.9999830567881718,0,0,1
489,Methylation Pathways WP704,0.8819989227057858,0.4668095238095238,0.05861467849688599,['MAT2B'],0.9999830567881718,0,0,1
490,Mevalonate pathway WP3963,0.8819989227057858,0.4668095238095238,0.05861467849688599,['PMVK'],0.9999830567881718,0,0,1
491,Supression of HMGB1 mediated inflammation by THBD WP4479,0.8819989227057858,0.4668095238095238,0.05861467849688599,['NFKB1'],0.9999830567881718,0,0,1
492,Type III interferon signaling WP2113,0.8819989227057858,0.4668095238095238,0.05861467849688599,['STAT1'],0.9999830567881718,0,0,1
493,Urea cycle and related diseases WP4571,0.8819989227057858,0.4668095238095238,0.05861467849688599,['CPS1'],0.9999830567881718,0,0,1
494,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.8894880574707887,0.5599771297884505,0.06557847261338619,"['B3GALNT1', 'B3GALT1', 'ST6GALNAC3']",0.9999830567881718,0,0,3
495,Monoamine Transport WP727,0.8894880574707887,0.5599771297884505,0.06557847261338619,"['PPP2CB', 'TDO2', 'ADORA2A']",0.9999830567881718,0,0,3
496,Vitamin D in inflammatory diseases WP4482,0.8894880574707887,0.5599771297884505,0.06557847261338619,"['MAP3K1', 'DUSP1', 'NFKB1']",0.9999830567881718,0,0,3
497,Interleukin-11 Signaling Pathway WP2332,0.8899916019788886,0.6530528525090632,0.07610890334164597,"['MAP2K1', 'TGFB1', 'STAT1', 'RPS6', 'JAK2', 'HRAS', 'MAPK3']",0.9999830567881718,0,0,7
498,One-carbon metabolism and related pathways WP3940,0.8899916019788886,0.6530528525090632,0.07610890334164597,"['DMGDH', 'GPX4', 'GPX3', 'CHDH', 'DNMT3A', 'SOD2', 'SOD1']",0.9999830567881718,0,0,7
499,Ethanol effects on histone modifications WP3996,0.8911847880047743,0.5893773610463103,0.0678983224774693,"['KAT2B', 'AHCY', 'ALDH1A1', 'HDAC9']",0.9999830567881718,0,0,4
500,Transcription co-factors SKI and SKIL protein partners WP4533,0.8934350524760207,0.5091324794097015,0.05736988067758713,"['ING2', 'MERTK']",0.9999830567881718,0,0,2
501,Tumor suppressor activity of SMARCB1 WP4204,0.8952407359619606,0.6085215401452592,0.06734058683139625,"['H3F3B', 'CDKN2A', 'PTCH1', 'H3F3A', 'EZH2']",0.9999830567881718,0,0,5
502,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9003017875842013,0.6219678906374185,0.06532233465339762,"['ACTA2', 'ACTC1', 'YWHAQ', 'NF2', 'ACTB', 'ACTG1']",0.9999830567881718,0,0,6
503,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9037741942053324,0.6627102550189907,0.06705019711877508,"['IFIH1', 'TKFC', 'MAP3K1', 'TRAF3', 'TRADD', 'PIN1', 'ISG15', 'FADD', 'NFKB1']",0.9999830567881718,0,0,9
504,Lung fibrosis WP3624,0.9101106165176455,0.5598513011152416,0.05273190711905237,"['CEBPB', 'TGFB1', 'EGF', 'FGF1']",0.9999830567881718,0,0,4
505,Sphingolipid pathway WP1422,0.9101106165176455,0.5598513011152416,0.05273190711905237,"['PPP2CA', 'CERS4', 'GAL3ST1', 'SERINC1']",0.9999830567881718,0,0,4
506,Angiogenesis WP1539,0.9105633024415999,0.5249249571183533,0.04918119418031253,"['PDGFRA', 'TIMP2', 'TIMP3']",0.9999830567881718,0,0,3
507,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.9105633024415999,0.5249249571183533,0.04918119418031253,"['H3F3B', 'SUV39H1', 'H3F3A']",0.9999830567881718,0,0,3
508,TLR4 Signaling and Tolerance WP3851,0.9105633024415999,0.5249249571183533,0.04918119418031253,"['IRAK1', 'TRAF3', 'NFKB1']",0.9999830567881718,0,0,3
509,Trans-sulfuration and one-carbon metabolism WP2525,0.9105633024415999,0.5249249571183533,0.04918119418031253,"['AHCY', 'DNMT3A', 'MAT2B']",0.9999830567881718,0,0,3
510,ATR Signaling WP3875,0.9130533031408486,0.40008163265306124,0.03639183246151328,['RAD9A'],0.9999830567881718,0,0,1
511,Heme Biosynthesis WP561,0.9130533031408486,0.40008163265306124,0.03639183246151328,['UROD'],0.9999830567881718,0,0,1
512,Mitochondrial CII Assembly WP4920,0.9130533031408486,0.40008163265306124,0.03639183246151328,['SDHAF1'],0.9999830567881718,0,0,1
513,Nephrotic syndrome WP4758,0.9155654833665081,0.5996934396076027,0.05290099126302532,"['CUBN', 'TRPC6', 'ARHGDIA', 'LMNA', 'PMM2', 'PDSS2']",0.9999830567881718,0,0,6
514,Phosphoinositides metabolism WP4971,0.9155654833665081,0.5996934396076027,0.05290099126302532,"['PIP4P1', 'PIK3CD', 'PIP5K1B', 'PLCH1', 'PIP4K2C', 'PLCB2']",0.9999830567881718,0,0,6
515,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.9165159419796963,0.46665714013527676,0.040681217655720046,"['FRAT1', 'MAP3K1']",0.9999830567881718,0,0,2
516,NAD+ metabolism WP3644,0.9165159419796963,0.46665714013527676,0.040681217655720046,"['NMNAT1', 'NMNAT3']",0.9999830567881718,0,0,2
517,Riboflavin and CoQ disorders WP5037,0.9165159419796963,0.46665714013527676,0.040681217655720046,"['RFK', 'PDSS2']",0.9999830567881718,0,0,2
518,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.9165159419796963,0.46665714013527676,0.040681217655720046,"['NFKBIE', 'NFKB1']",0.9999830567881718,0,0,2
519,IL-1 signaling pathway WP195,0.9165867528785814,0.6456515992598467,0.05623532421362865,"['MAP2K1', 'JUN', 'MAP3K1', 'IRAK1', 'TOLLIP', 'PELI2', 'UBE2N', 'NFKB1', 'MAPK3']",0.9999830567881718,0,0,9
520,Wnt signaling pathway and pluripotency WP399,0.9188136005651619,0.6991537578886976,0.05919875100535884,"['PRKCG', 'FZD1', 'JUN', 'PRKCH', 'CTBP2', 'PRKCD', 'TCF7', 'WNT7A', 'PPM1J', 'PPP2CA', 'PPP2CB', 'FRAT1', 'PRKCQ', 'PRKD1', 'WNT2']",0.9999830567881718,0,0,15
521,Male infertility WP4673,0.9211306551144169,0.7094864369313022,0.05828671634859947,"['SLC46A1', 'PACRG', 'ABCB1', 'HMGA1', 'PEX10', 'TEX15', 'SOD2', 'CLU', 'ETV5', 'AR', 'CYP26B1', 'SPATA17', 'MSH4', 'AHRR', 'HORMAD1', 'RAG1', 'SOX5']",0.9999830567881718,0,0,17
522,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9217532981694855,0.6505765656538741,0.05300745863638388,"['PTPRT', 'RPTOR', 'IFNAR2', 'PTPRD', 'PDGFRA', 'DUSP2', 'DEPTOR', 'STMN1', 'JAK2', 'MAPK3']",0.9999830567881718,0,0,10
523,Resistin as a regulator of inflammation WP4481,0.9260470309397093,0.5331372468918937,0.04096107130789513,"['PIK3CD', 'PLCB2', 'NFKB1', 'MAPK3']",0.9999830567881718,0,0,4
524,Fatty acid beta-oxidation WP143,0.9267225868098513,0.559725400457666,0.042595672387968554,"['TPI1', 'CPT2', 'LPL', 'ACSL5', 'CPT1B']",0.9999830567881718,0,0,5
525,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9279187194930459,0.4939965694682676,0.03695644492984264,"['TICAM2', 'IRAK1', 'NFKB1']",0.9999830567881718,0,0,3
526,Fragile X Syndrome  WP4549,0.9342835990978539,0.7290392767378174,0.049556625310881494,"['GABRA1', 'MAP2K1', 'DUSP3', 'KCND2', 'BDNF', 'CDKN2A', 'GAB1', 'AKAP5', 'DNM2', 'EEF1A1', 'RPTOR', 'GRIP1', 'ARC', 'DEPTOR', 'PRKAR1A', 'CLTCL1', 'AP2S1', 'CAMK1', 'SOS1', 'GABRD', 'AP2M1', 'EIF4G1', 'SHANK1', 'HCN1']",0.9999830567881718,0,0,24
527,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.934831024694138,0.4307164684415327,0.029025762401157604,"['MAP2K1', 'MAPK3']",0.9999830567881718,0,0,2
528,Glycosaminoglycan degradation WP4815,0.934831024694138,0.4307164684415327,0.029025762401157604,"['HYAL2', 'IDS']",0.9999830567881718,0,0,2
529,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.934831024694138,0.4307164684415327,0.029025762401157604,"['STK38', 'EZH2']",0.9999830567881718,0,0,2
530,15q11.2 copy number variation syndrome WP4940,0.9359366773465625,0.3500357142857143,0.02317497457224974,['TUBGCP4'],0.9999830567881718,0,0,1
531,Autosomal recessive Osteopetrosis pathways WP4788,0.9359366773465625,0.3500357142857143,0.02317497457224974,['NFKB1'],0.9999830567881718,0,0,1
532,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.9359366773465625,0.3500357142857143,0.02317497457224974,['BMPR1B'],0.9999830567881718,0,0,1
533,Ras signaling WP4223,0.936505241280977,0.7483176935424126,0.04908976075959017,"['SHC4', 'RAB5C', 'FLT3', 'PIK3R3', 'PIK3CD', 'FOXO4', 'ELK1', 'ETS2', 'IGF1R', 'GNG10', 'GNG3', 'ABL1', 'RAC3', 'RAC1', 'HRAS', 'MAPK3', 'PRKCG', 'PDGFRA', 'MAP2K1', 'BAD', 'GAB1', 'RRAS2', 'KSR2', 'GAB2', 'NFKB1', 'CALM3', 'CALM1', 'SOS1', 'CALM2', 'ARF6']",0.9999830567881718,0,0,30
534,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9378855637447464,0.6140306763892381,0.03937615253724704,"['KIRREL3', 'CDKN1A', 'CDKN1B', 'TRPC6', 'PCNA', 'TGFB1', 'JAG1', 'YWHAQ', 'LIMS1']",0.9999830567881718,0,0,9
535,Lipid Metabolism Pathway WP3965,0.9393896159938074,0.5088517430524866,0.03181593453482627,"['ACLY', 'PRKAR1A', 'HILPDA', 'ACACA']",0.9999830567881718,0,0,4
536,miRNA regulation of p53 pathway in prostate cancer WP3982,0.942126902780831,0.466504669334858,0.02781081448489335,"['ZMAT3', 'EI24', 'BAX']",0.9999830567881718,0,0,3
537,Sphingolipid Metabolism (general overview) WP4725,0.942126902780831,0.466504669334858,0.02781081448489335,"['CERS4', 'SMPD1', 'DEGS1']",0.9999830567881718,0,0,3
538,TGF-beta Signaling Pathway WP366,0.9447212115079612,0.7066504115001999,0.04018396487558174,"['KLF10', 'MAP2K1', 'JUN', 'CDKN1A', 'TGFB1', 'JUND', 'CITED1', 'LIMK2', 'FN1', 'NEDD9', 'FOS', 'TGFBR1', 'TGFBR3', 'DAB2', 'RBL1', 'ZEB1', 'PARD6A', 'SUMO1', 'STRAP', 'RAC1', 'SOS1', 'SKP1']",0.9999830567881718,0,0,22
539,Chemokine signaling pathway WP3929,0.9468730354642525,0.6986350574712644,0.03813867295623314,"['SHC4', 'VAV3', 'MAP2K1', 'STAT1', 'PRKCD', 'PXN', 'PIK3R3', 'PIK3CD', 'NFKB1', 'VAV2', 'GNG10', 'GNG3', 'ADCY9', 'GRK5', 'PARD3', 'RAC1', 'JAK2', 'SOS1', 'HRAS', 'PLCB2', 'MAPK3']",0.9999830567881718,0,0,21
540,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.9492898167803254,0.3999101784183236,0.020811779676797336,"['PTGDR', 'PTGES']",0.9999830567881718,0,0,2
541,Kallmann's Syndrome WP5074,0.9492898167803254,0.3999101784183236,0.020811779676797336,"['ANOS1', 'PRKCQ']",0.9999830567881718,0,0,2
542,Hedgehog Signaling Pathway WP4249,0.9494868516514431,0.5181583185015679,0.02685800919438929,"['EVC', 'HHIP', 'SUFU', 'PTCH1', 'CDON']",0.9999830567881718,0,0,5
543,Integrated Cancer Pathway WP1971,0.9497766080074993,0.5414924546587291,0.027902278520223422,"['BARD1', 'CDKN1A', 'CDKN1B', 'STAT1', 'BAD', 'BAX']",0.9999830567881718,0,0,6
544,Intraflagellar transport proteins binding to dynein WP4532,0.9505019629544803,0.4866780221556365,0.024706235041079803,"['DYNLT3', 'DYNLRB1', 'DYNLL1', 'DYNLL2']",0.9999830567881718,0,0,4
545,MECP2 and Associated Rett Syndrome WP3584,0.9518400208459489,0.6151805157593123,0.03036426669140162,"['RBFOX1', 'FUT8', 'CNP', 'GRID1', 'BDNF', 'RPS6', 'TAP1', 'IGF1R', 'CDON', 'FKBP5', 'EZH2']",0.9999830567881718,0,0,11
546,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.9527985363862437,0.3111111111111111,0.01504278130779776,['IFIH1'],0.9999830567881718,0,0,1
547,TCA cycle in senescence WP5050,0.9527985363862437,0.3111111111111111,0.01504278130779776,['GOT1'],0.9999830567881718,0,0,1
548,Gastric Cancer Network 2 WP2363,0.9536970397931586,0.44190665342601787,0.02095045254474,"['S100A6', 'CACYBP', 'COL9A3']",0.9999830567881718,0,0,3
549,Sphingolipid Metabolism (integrated pathway) WP4726,0.9536970397931586,0.44190665342601787,0.02095045254474,"['CERS4', 'SMPD1', 'DEGS1']",0.9999830567881718,0,0,3
550,Integrin-mediated Cell Adhesion WP185,0.9563735581690039,0.6450417052826691,0.02877317604985058,"['VAV3', 'MAP2K1', 'CAV3', 'ITGA4', 'CAV2', 'PXN', 'VAV2', 'CAPNS1', 'ITGA10', 'RAC3', 'RAC1', 'SOS1', 'HRAS', 'MAP2K5', 'ITGA9']",0.9999830567881718,0,0,15
551,Notch Signaling WP268,0.9582698534379414,0.49960158548545275,0.021295945491873053,"['KAT2B', 'JAG1', 'CTBP2', 'NOTCH4', 'DLL3']",0.9999830567881718,0,0,5
552,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9597121164260861,0.466352111333524,0.019177293381974984,"['SUPT4H1', 'NFATC3', 'HDAC9', 'NFKB1']",0.9999830567881718,0,0,4
553,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9606532317107613,0.37321139373154233,0.014981368250850127,"['PYGO1', 'FLT3']",0.9999830567881718,0,0,2
554,Cannabinoid receptor signaling WP3869,0.963073818845815,0.4197684391080618,0.0157938777875822,"['ADORA2A', 'PRKAR1A', 'MAPK3']",0.9999830567881718,0,0,3
555,Hematopoietic Stem Cell Differentiation WP2849,0.963073818845815,0.4197684391080618,0.0157938777875822,"['FOS', 'ABO', 'RUNX1']",0.9999830567881718,0,0,3
556,Wnt signaling in kidney disease WP4150,0.963073818845815,0.4197684391080618,0.0157938777875822,"['FZD1', 'WNT7A', 'WNT2']",0.9999830567881718,0,0,3
557,Regulation of Microtubule Cytoskeleton WP2038,0.9650396086007668,0.5085706853947197,0.018098064204627406,"['PARD6A', 'CFL2', 'STMN1', 'ABL1', 'TESK2', 'RAC1']",0.9999830567881718,0,0,6
558,Mammalian disorder of sexual development WP4842,0.9652230389327104,0.2799714285714286,0.009909889941574063,['AMH'],0.9999830567881718,0,0,1
559,NO metabolism in cystic fibrosis WP4947,0.9652230389327104,0.2799714285714286,0.009909889941574063,['PRMT3'],0.9999830567881718,0,0,1
560,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.969548808838931,0.34984995713060874,0.010818921433966223,"['MDH2', 'IDH3B']",0.9999830567881718,0,0,2
561,Wnt Signaling Pathway WP363,0.9707950797466414,0.5151462657789293,0.015268870094338987,"['PRKCG', 'GSK3A', 'FRAT1', 'PPARG', 'ROR1', 'PIP5K1B', 'RAC1']",0.9999830567881718,0,0,7
562,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.9764882134376965,0.32923692483566736,0.007833402112324563,"['FLT3', 'DNMT3A']",0.9999830567881718,0,0,2
563,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9801219636445789,0.46604673342870767,0.009357408586997585,"['CYP27A1', 'IDI1', 'ELOVL2', 'PMVK', 'MSMO1', 'DHCR24']",0.9999830567881718,0,0,6
564,Omega-3/Omega-6 FA synthesis WP4723,0.9811227978724958,0.23326190476190475,0.00444542397953952,['ELOVL2'],0.9999830567881718,0,0,1
565,Omega-9 FA synthesis WP4724,0.9811227978724958,0.23326190476190475,0.00444542397953952,['ELOVL2'],0.9999830567881718,0,0,1
566,DNA Repair Pathways Full Network WP4946,0.9816817601357009,0.6304412309974046,0.011655658210533736,"['XRCC6', 'FEN1', 'DCLRE1C', 'PCNA', 'CENPX', 'MPG', 'CETN2', 'H2AFX', 'RPA2', 'APEX2', 'RAD23A', 'FANCF', 'POLE4', 'POLD4', 'NEIL2', 'RPA3', 'POLE2', 'APEX1', 'POLD2', 'POLE3', 'USP1']",0.9999830567881718,0,0,21
567,Signal Transduction of S1P Receptor WP26,0.9818847600925343,0.31091422946238606,0.005683925556473072,"['PLCB2', 'MAPK3']",0.9999830567881718,0,0,2
568,Joubert Syndrome WP4656,0.9858607558019451,0.5298932911767612,0.007545762943383873,"['TMEM17', 'KAT5', 'CETN2', 'SUFU', 'BBS9', 'ANKS6', 'ARL2', 'CEP41', 'B9D2', 'ZNF423', 'ATF4']",0.9999830567881718,0,0,11
569,Glycerolipids and Glycerophospholipids WP4722,0.9860697367401837,0.2945202388652397,0.004131588804102334,"['DGAT2', 'CDIPT']",0.9999830567881718,0,0,2
570,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9897539300522231,0.19989795918367348,0.0020587335398351667,['CPT2'],0.9999830567881718,0,0,1
571,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.9897539300522231,0.19989795918367348,0.0020587335398351667,['PPARA'],0.9999830567881718,0,0,1
572,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.9897539300522231,0.19989795918367348,0.0020587335398351667,['ACLY'],0.9999830567881718,0,0,1
573,Netrin-UNC5B signaling pathway WP4747,0.9911875653727796,0.36078850996706857,0.003193517248015879,"['MAP2K1', 'JUN', 'RAC1', 'MAPK3']",0.9999830567881718,0,0,4
574,Integrated breast cancer pathway WP1984,0.9913342924395722,0.6053386787027895,0.005268548930361181,"['BARD1', 'PLK3', 'JUN', 'GSK3A', 'ANXA1', 'GADD45A', 'STAT1', 'BAD', 'ZMYND8', 'TRADD', 'ODC1', 'PHB', 'JAKMIP1', 'NFKB1', 'TGFBR1', 'DHTKD1', 'AR', 'FER', 'ABL1', 'BAX', 'FADD', 'RAC1', 'FAU']",0.9999830567881718,0,0,23
575,Thermogenesis WP4321,0.9931213932295009,0.5368176000706121,0.003705315542948435,"['RPS6', 'ACSL5', 'CPT1B', 'ACTB', 'ACTG1', 'RPTOR', 'ADCY10', 'CREB3', 'ADCY9', 'CPT2', 'RPS6KA2', 'ZNF516', 'PPARG', 'SOS1', 'HRAS']",0.9999830567881718,0,0,15
576,Energy Metabolism WP1541,0.9933871001151512,0.3777289875688045,0.0025061796994752515,"['UCP3', 'PPARG', 'NRF1', 'PPARA', 'MEF2D']",0.9999830567881718,0,0,5
577,Fluoropyrimidine Activity WP1601,0.9937293555216756,0.2542804437631531,0.0015995225369430112,"['DPYS', 'UPP2']",0.9999830567881718,0,0,2
578,Mitochondrial Gene Expression WP391,0.9944387866063126,0.174875,0.0009752314477521558,['NRF1'],0.9999830567881718,0,0,1
579,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9947703762680551,0.5579551981619759,0.0029255521993362117,"['ABCG8', 'MAP2K1', 'GSK3A', 'MAP3K1', 'THRA', 'SLC2A1', 'LPL', 'PIK3R3', 'PIK3CD', 'RPTOR', 'MLXIPL', 'GYS1', 'RPS6KA5', 'RPS6KA2', 'MAP3K8', 'SOS1', 'HRAS', 'MAP2K5', 'MAPK3']",0.9999830567881718,0,0,19
580,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9959028383748504,0.16457142857142856,0.0006756608346801458,['MAP1LC3A'],0.9999830567881718,0,0,1
581,Rett syndrome causing genes WP4312,0.9977968477870568,0.3325909883404163,0.000733556937806318,"['SRRM3', 'EIF2B2', 'IMPDH2', 'TBL1X', 'GABRD']",0.9999830567881718,0,0,5
582,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9978368073979615,0.3988793914359331,0.000863787555283409,"['ACLY', 'IDI1', 'CDK8', 'GSK3A', 'RBP4', 'LPL', 'PPARG', 'ACACA']",0.9999830567881718,0,0,8
583,Pathways affected in adenoid cystic carcinoma WP3651,0.9978945886005001,0.35657017623961285,0.0007515183192955848,"['CEBPA', 'KANSL1', 'CNTN6', 'MAGI2', 'HRAS', 'FOXP2']",0.9999830567881718,0,0,6
584,mRNA Processing WP411,0.9981947196123987,0.5259278129793542,0.0009503052080660909,"['SF3B5', 'SF3A1', 'NCBP2', 'CSTF2T', 'SNU13', 'HNRNPAB', 'LSM2', 'PRPF4', 'NUDT21', 'LSM7', 'HNRNPK', 'SNRPD1', 'SNRPG', 'CD2BP2', 'SRSF3', 'SNRPE', 'HNRNPH2', 'SNRPB2', 'HNRNPA1', 'SRSF9']",0.9999830567881718,0,0,20
585,DNA IR-damage and cellular response via ATR WP4016,0.9984135521036192,0.40517958097771867,0.0006433067152220232,"['BARD1', 'UPF1', 'FEN1', 'PCNA', 'H2AFX', 'USP1', 'RPA2', 'MCPH1', 'RAD9A']",0.9999830567881718,0,0,9
586,Nanoparticle triggered autophagic cell death WP2509,0.9987922171628429,0.13317006802721087,0.00016093773107669971,['MAP1LC3A'],0.9999830567881718,0,0,1
587,Ciliopathies WP4803,0.9997676082908988,0.4946281916083469,0.00011496084930904818,"['DNAH11', 'C2CD3', 'SCLT1', 'PKD1L1', 'CFAP410', 'CCDC28B', 'TMEM17', 'BBS10', 'EVC', 'ARL2BP', 'BBS12', 'SUFU', 'NEK1', 'ANKS6', 'BBS9', 'CCDC65', 'RAB28', 'CEP41', 'B9D2', 'CCNQ', 'ZNF423', 'CCDC151', 'KIZ', 'CCNO']",0.9999830567881718,0,0,24
588,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999830567881718,0.3093351156943251,5.241174792406516e-06,"['TMEM17', 'BBS10', 'EVC', 'C2CD3', 'BBS12', 'CDK20', 'SCLT1', 'BBS9', 'TULP3', 'DYNLL1']",0.9999830567881718,0,0,10
